Kur IdNavnDagerEndret
163330 Standard21Z51.100023 5FU / Streptozocin vedlikehold109.03.2010 13:32:49
162787 Standard0Z51.100185 5FU/Follinat205.03.2009 13:58:57
163183 Standard21Z51.100848 5-FU/Streptozocin over 2dg vedlike208.01.2010 08:22:02
161193 Studie0Z51.100751 ABR-217620329.11.2005 12:05:27
163318 Standard28Z51.100453 ABVD / hele kuren 1503.03.2010 10:29:52
163100 Standard28Z51.100304 ABVD dag 1 og 15128.08.2009 13:39:48
161623hhe Standard28Z51.100448 ABVP1426.01.2006 13:35:00
161848ssu Standard21Z51.100033 ACO 104.12.2006 14:13:55
162788 Standard0Z51.100511 AdriaHoloxanIntensivert405.03.2009 14:04:33
162789 Standard0Z51.100528 AdriaHoloxanSSG13205.03.2009 14:07:24
163387 Standard0Z51.120660 ALIMTA + Cisplatin107.12.2010 09:49:29
163388 Standard21Z51.120663 Alimta 500mg/m2107.12.2010 09:50:00
163259 Standard21Z51.120750 Alimta 500mg/m2 lunge125.02.2010 09:36:51
163389 Standard21Z51.120692 Alimta-Carboplatin, mesotheliom107.12.2010 09:50:39
162051 Standard0Z51.100866 ALL Induksjon Hammersmith RAT516.09.2008 10:06:24
162595 Standard0Z51.100963 ALL, AML - MTX intrathekal 15 mg118.09.2008 10:59:59
162108 Standard0Z51.100226 ALL, Vedlikehold syklus 10-131507.03.2008 09:33:53
162573 Standard0Z51.100971 AlloTx Liten BuCy2016.09.2008 12:51:42
162923 Standard0Z51.100876 ALL-REZ BFM 2002 block F1620.03.2009 16:08:05
162924 Standard0Z51.100877 ALL-REZ BFM 2002 block F2520.03.2009 16:11:10
162925 Standard0Z51.100878 ALL-REZ BFM 2002 block R1620.03.2009 16:18:59
162926 Standard0Z51.100879 ALL-REZ BFM 2002 block R2620.03.2009 16:20:35
162377 Standard0Z51.100239 AML Høydose Cytarabin Konsolidering301.07.2008 13:06:47
162372 Standard0Z51.100228 AML Induksjon (3/7) < 60 år RH330.06.2008 13:45:01
162374 Standard0Z51.100232 AML Induksjon 3 M5A5E5 < 60 år RH530.06.2008 14:36:03
162373 Standard0Z51.100230 AML Induksjon II, 2(2/5) <60 år RH330.06.2008 13:46:02
162375 Standard0Z51.100236 AML Konsolidering I N3A5 < 60 år RH201.07.2008 10:51:24
162716 Standard0Z51.100238 AML Konsolidering II M3A5E3 <60 RH 224.11.2008 16:57:07
163446 Standard21Z51.101157 Avastin Aurelia hver 14. dag116.05.2011 08:01:58
163447 Standard21Z51.101150 Avastin Aurelia hver 3. uke116.05.2011 08:04:59
163282 Standard14Z51.110733 Avastin hver 14. dag125.02.2010 10:25:03
163267 Standard0Z51.121042 Avastin hver 14. dag, ca. renis125.02.2010 09:45:49
163482 Standard21Z51.110765 Avastin hver 3. uke119.08.2011 14:58:22
163481 Studie0Z51.100852 Avastin hver 3. uke ICON7119.08.2011 14:58:52
163448 Standard21Z51.101158 Avastin hver 3. uke OCTAVIA116.05.2011 08:05:35
163508 Standard21Z51.100875 AVD (Velcade)1109.12.2011 12:55:27
163360 Standard56Z51.100047 AVOP/ hele kuren 1404.06.2010 13:14:03
163340 Standard21Z51.100557 BEACOPP- doseeskalert (dag 1-3)324.03.2010 14:16:46
163207 Standard21Z51.100558 BEACOPP- doseeskalert (dag 8)122.03.2010 13:53:11
163203 Standard21Z51.100473 BEACOPP- standard (dag 1-3)324.03.2010 14:14:28
163056 Standard21Z51.100474 BEACOPP- standard (dag 8)125.05.2009 13:18:15
163206 Standard21Z51.100472 BEACOPP standard hele kuren816.12.2011 13:53:53
163237 Standard0Z51.100003 BEAM_etopofos516.02.2010 10:46:49
163296 Standard0Z51.111049 Bendamustine (Ribomustin)225.02.2010 10:40:58
163251 Standard0Z51.131048 Bendamustine (Ribomustin)-rituximab225.02.2010 09:24:43
162917 Standard21Z51.100138 BEP, hele kuren1513.03.2009 13:52:58
162912 Standard21Z51.100139 BEP-5 dager513.03.2009 13:49:09
162907 Standard21Z51.100141 BEP-Ifosfamid / hele kuren 1513.03.2009 13:12:58
162916 Standard21Z51.100142 BEP-Ifosfamid /del A 513.03.2009 13:52:35
162911 Standard21Z51.100143 BEP-Ifosfamid /del B (Bleo dag 15 )113.03.2009 13:48:49
162910 Standard0Z51.100140 Bleo Dag 15113.03.2009 13:31:15
162682 Standard0Z51.101064 Bleomycin intrapleuralt101.12.2008 12:51:12
162927 Standard0Z51.100880 Block R1-modif NOPHO-ALL residiv325.03.2009 11:00:58
162928 Standard0Z51.100881 Block R2-modif NOPHO-ALL residiv525.03.2009 13:12:23
162658 Standard0Z51.100522 Blokk A < 55 år514.10.2008 10:35:51
163243 Standard0Z51.100547 Blokk B <55 år, GMALL02523.02.2010 09:42:19
163247 Standard0Z51.100524 Blokk B1>55 årMTX 0,5g/m2GMALL02523.02.2010 09:52:31
163244 Standard0Z51.100529 Blokk B2>55 MTX 1,5g/m2, GMALL02523.02.2010 09:43:13
163238 Standard0Z51.100525 Blokk C uten rituximab BFM522.02.2010 15:08:33
163503 Standard0Z51.101131 Blokk C< 55 år, GMALL02502.12.2011 13:12:36
162653 Standard21Z51.100681 Blokk CC513.10.2008 14:23:43
163348 Standard0Z51.100523 BlokkA1>55 -MTX 0,5g/m2,GMALL02520.04.2010 12:47:25
163246 Standard0Z51.100552 BlokkA2>55 MTX 1,5g/m2, GMALL02523.02.2010 09:46:02
162929 Standard0Z51.100883 B-NHL BFM 04 Kur A24 (mediastinal)725.03.2009 13:16:14
162930 Standard0Z51.100882 B-NHL BFM 04 Kur A4725.03.2009 13:16:42
162931 Standard0Z51.100884 B-NHL BFM 04 Kur B24 (mediastinal)725.03.2009 13:18:56
162932 Standard0Z51.100885 B-NHL BFM 04 Kur B4725.03.2009 13:31:04
162933 Standard0Z51.100947 B-NHL BFM 04 Kur BB24725.03.2009 13:31:31
162934 Standard0Z51.100948 B-NHL BFM 04 Kur CC525.03.2009 13:32:06
162935 Standard0Z51.100949 B-NHL BFM 04 Kur AA24725.03.2009 13:35:52
162936 Standard0Z51.100950 B-NHL BFM 04 Vorfase V325.03.2009 13:37:17
162937 Standard0Z51.100951 B-NHL BFM 04 Vorfase VZ325.03.2009 13:40:47
162766 Standard28Z51.100091 BOP (dag 1, 8)126.01.2009 15:45:43
161513hhe Standard28Z51.100092 BOP (dag 15, 22)122.03.2006 13:27:37
161717hhe Standard28Z51.100090 BOP/ hele kuren 2222.03.2006 13:26:34
163502 Standard21Z51.110794 Bortezomid/ Dexametason 2 dager223.11.2011 13:15:40
162938 Standard0Z51.100994 BUMEL melfalanbestilling barn125.03.2009 13:42:26
162356 Standard0Z51.100572 C1Eto1417.06.2008 14:08:29
162357 Standard0Z51.100567 C2Eto2417.06.2008 14:18:49
163475 Standard21Z51.131168 Cabazitaxel110.08.2011 10:26:19
162939 Standard0Z51.100952 CADO nevroblastom525.03.2009 13:49:58
163313 Standard28Z51.100576 Caelyx125.02.2010 11:27:35
163307 Standard21Z51.100640 Caelyx og Streptozotocin vedlikehold125.02.2010 11:07:18
163320 Standard14Z51.100635 Caelyx-Kaposi 103.03.2010 10:31:52
163184 Standard21Z51.100639 Caelyx-Streptozotocin induksjonskur508.01.2010 08:24:07
163421 Standard21Z51.131152 Caleyx Trabectidine114.03.2011 08:34:30
162113 Standard0Z51.100645 CAMPATH-1H110.03.2008 08:42:20
162221 Standard0Z51.100904 CAMPATH-1H, subcutan129.04.2008 11:58:01
162114 Standard0Z51.100644 CAMPATH-1H-oppstart310.03.2008 08:43:26
161255due Standard0Z51.100012 Campto115.08.2005 13:32:46
162317 Standard0Z51.100932 Campto- EMR (over 70 år)122.05.2008 09:22:39
163329 Standard0Z51.100929 CAP - sarkom109.03.2010 13:32:02
162422 Standard21Z51.100964 Capecitabine po1421.08.2008 13:38:37
162174 Standard35Z51.100813 Capecitabine stråle531.03.2008 10:04:47
162175 Standard35Z51.100812 Capecitabine stråle dag 1131.03.2008 10:06:23
162901 Standard0Z51.101060 Carbo - Paklitaxel Hypersens112.03.2009 17:09:42
163166 Standard21Z51.100582 Carbo 5/ Navelbine 25, dag 1124.11.2009 13:54:19
163168 Standard21Z51.100583 Carbo 5/ Navelbine 25, dag 8124.11.2009 14:02:19
163167 Standard21Z51.100581 Carbo 5/ Navelbine 25, hele kuren824.11.2009 13:58:26
163176 Standard21Z51.100778 Carbo 6/Navelbine 30 adjuvant dag 1116.12.2009 09:38:13
162940 Standard0Z51.100953 Carbo/Eto nevroblastom325.03.2009 13:50:53
162941 Standard0Z51.100954 Carbo/Eto Sasilidar325.03.2009 13:53:49
162799 Standard21Z51.100198 Carboplatin105.03.2009 16:10:23
163304 Standard28Z51.100805 Carboplatin - Caelyx125.02.2010 11:04:06
163449 Standard21Z51.101143 Carboplatin - Etoposid316.05.2011 08:06:04
162919 Standard0Z51.100451 Carboplatin AUC 7113.03.2009 13:53:51
162801 Standard21Z51.100717 Carboplatin/Epirubicin105.03.2009 16:12:42
162858 Studie21Z51.100821 Carboplatin/Etoposid-Sarkom412.03.2009 12:40:18
163382 Standard42Z51.100113 CCNU 107.12.2010 09:46:36
162852 Standard0Z51.100737 CDP/ADM-Euroboss1-hørselproblemer612.03.2009 12:20:23
162856 Standard0Z51.100584 CDP1/ADM1 SSG14312.03.2009 12:38:51
162845 Standard0Z51.100440 CDP1/ADM1barn ISG/SSG I312.03.2009 10:41:49
162846 Standard0Z51.100257 CDP1/ADM1voksneISG/SSG I312.03.2009 10:51:23
162853 Standard21Z51.100677 CDP100/ ADM60312.03.2009 12:37:27
162920 Standard0Z51.100152 CEB Dag 1-6613.03.2009 13:54:47
161790hhe Standard28Z51.100305 CEKP523.06.2006 15:09:00
163487 Standard7Z51.110699 Cetuximab - vedlikehold (hver uke)102.09.2011 16:07:28
163291 Standard0Z51.110862 Cetuximab rutine startdose 1.kur125.02.2010 10:35:40
162878 Standard0Z51.100690 CEV112.03.2009 15:10:00
161593hhe Standard14Z51.100598 CHOEP-14513.12.2005 08:58:55
162673 Standard14Z51.100697 CHOEP-14 + Rituximab524.11.2008 16:14:26
163262 Standard14Z51.120799 CHOEP-14 + Rituximab dag 1125.02.2010 09:39:43
161684hhe Standard14Z51.100800 CHOEP-14 + Rituximab dag 2-5428.03.2006 11:46:19
161549hhe Standard21Z51.100668 CHOEP-21505.12.2005 08:19:13
160799hhe Standard21Z51.100725 CHOEP21 Rituximab 329.11.2005 07:39:16
161545hhe Standard14Z51.100615 CHOP-14102.12.2005 14:45:08
163094 Standard14Z51.120730 CHOP-14 + Rituximab514.07.2009 09:54:25
162691 Standard0Z51.100062 CHOP-21103.11.2008 14:20:16
163339 Standard21Z51.120632 CHOP-21 + Rituximab124.03.2010 13:30:29
163369 Standard21Z51.100603 CiFu - øsofagus 516.08.2010 13:33:20
163370 Standard0Z51.100720 CiFu Ani/ Spiserør416.08.2010 13:34:13
163368 Standard21Z51.101139 CiFu NeoRes516.08.2010 13:32:06
161376due Standard0Z51.100719 CiFu Stråle411.10.2005 12:59:16
163371 Standard0Z51.100175 CiFu ØNH516.08.2010 13:35:44
163309 Standard21Z51.100766 Cis 75 - Docetaxel 75125.02.2010 11:21:09
162820 Standard0Z51.101056 Cis/Paclitaxel 3 timer111.03.2009 12:41:25
162086 Standard0Z51.100669 Cis/Paclitaxel/Gemcitabine114.02.2008 08:36:05
162625 Standard21Z51.100164 CisMtxLv522.09.2008 15:21:11
162851 Standard0Z51.100770 Cisplatin 120/Doxorubicin75312.03.2009 10:56:03
162821 Standard21Z51.100542 Cisplatin 2 dager211.03.2009 12:42:01
162834 Standard0Z51.100715 Cisplatin 4 dager411.03.2009 13:46:50
163450 Standard21Z51.101160 Cisplatin 50 Hypersens116.05.2011 08:06:33
163451 Standard21Z51.101161 Cisplatin 50 mg116.05.2011 08:07:05
162832 Standard21Z51.100802 Cisplatin 50 mg / Topotekan 0,75 mg311.03.2009 13:43:08
163305 Standard21Z51.100817 Cisplatin 50/Caelyx 30125.02.2010 11:05:13
162802 Standard21Z51.100194 Cisplatin 75 mg105.03.2009 16:13:29
162827 Standard21Z51.100806 Cisplatin 75 mg 2 dager211.03.2009 13:40:45
162831 Standard21Z51.100716 Cisplatin 75/Gemcitabine 1000mg211.03.2009 13:42:36
162830 Standard21Z51.100722 Cisplatin 75/Gemcitabine 800mg211.03.2009 13:42:13
162824 Standard7Z51.100494 Cisplatin ukentlig111.03.2009 12:58:44
162542 Standard0Z51.101041 Cisplatin ukentlig - DAHANCA 19101.09.2008 13:18:10
163420 Standard7Z51.101164 Cisplatin ukentlig GAND Emesis112.08.2011 13:14:07
162687 Standard0Z51.101067 Cisplatin ukentlig, hode/hals217.11.2008 14:25:14
162829 Standard21Z51.100193 Cisplatin/5FU211.03.2009 13:41:45
161330 Standard21Z51.100767 Cisplatin/5-FU penis614.07.2006 08:40:21
163308 Standard21Z51.100809 Cisplatin/docetaxel125.02.2010 11:08:15
162817 Standard21Z51.100181 Cisplatin/Doksorubicin111.03.2009 12:18:34
162818 Standard21Z51.100543 Cisplatin/doxorubicin111.03.2009 12:24:27
162825 Standard0Z51.101037 Cisplatin/Paclitaxel 24 timer211.03.2009 12:59:49
162833 Studie7Z51.100786 Cisplatin40 Combretastatin ukedos111.03.2009 13:46:29
163376 Standard21Z51.100776 Cisplatin-Navelbine dag 1129.10.2010 11:21:37
161556hhe Standard21Z51.100064 CIVP (peroral CHOP) 306.12.2005 10:22:58
162793 Standard0Z51.101024 Cladribin-kur (LCH-S-98, terapiresistent LCH)505.03.2009 14:38:00
162626 Standard0Z51.100097 CMF122.09.2008 15:24:47
163115 Standard0Z51.100065 CNOP125.09.2009 10:49:30
162942 Standard0Z51.100955 CNS-PNET >4 år ETO/CARBO125.03.2009 15:37:34
162943 Standard0Z51.100956 CNS-PNET >4 år VCR/CCNU125.03.2009 15:48:36
163098 Standard0Z51.100957 CNS-PNET >4 år VCR/Cisplatin119.08.2009 16:22:51
162945 Standard0Z51.100958 CNS-PNET >4 år VCR/Cyklofosfamid125.03.2009 15:57:37
162946 Standard0Z51.100959 COJEC-A (vcr/carbo/eto)225.03.2009 15:58:42
162947 Standard0Z51.100960 COJEC-B (vcr/cisplatin)325.03.2009 16:02:46
162948 Standard0Z51.100961 COJEC-C (vcr/cyk/eto)325.03.2009 16:05:04
163101 Standard21Z51.100066 COP-21131.08.2009 12:55:03
163263 Standard21Z51.120810 COP-21 + Rituximab125.02.2010 09:40:29
162544 Standard0Z51.101043 COPDAC-dag 1-3 EURONET-PHL-C1301.09.2008 13:34:47
162545 Standard0Z51.101044 COPDAC-dag 8 EURONET-PHL-C1102.09.2008 11:04:33
162949 Standard0Z51.101061 COPP dag 1 Barn125.03.2009 16:05:49
162950 Standard0Z51.101062 COPP dag 8 Barn125.03.2009 16:17:14
162546 Standard0Z51.101045 COPP-dag 1 EURONET-PHL-C1102.09.2008 12:37:10
161803hhe Standard28Z51.100307 COPP-dag 1 og dag 8116.08.2006 10:13:21
162547 Standard0Z51.101046 COPP-dag 8 EURONET-PHL-C1102.09.2008 12:46:24
163111 Standard0Z51.100739 Cyklo/fludarabin for mini-allo507.09.2009 12:52:44
162371 Standard0Z51.100723 Cyklo/Topo526.06.2008 14:06:47
163260 Standard14Z51.120754 Cytarabin liposomal i.t.125.02.2010 09:37:50
162747 Standard0Z51.100487 Cytosar it 119.12.2008 12:49:39
159871gbk Standard0Z51.100183 Dactinomycin402.10.2008 13:42:42
162662 Standard0Z51.100693 DHAP214.10.2008 10:57:34
163264 Standard0Z51.120888 DHAP-rituximab225.02.2010 09:41:26
163310 Standard21Z51.100785 Docetax75 Epirubi 60 Carbo5 TEC125.02.2010 11:25:08
163300 Standard0Z51.101038 Docetaxel 75125.02.2010 10:52:25
163463 Standard21Z51.100718 Docetaxel 75/ Carbo 5120.05.2011 14:16:24
163302 Standard21Z51.100626 Docetaxel 75/ prednison 10125.02.2010 11:00:51
163316 Studie7Z51.100712 Docetaxel ukedose, 30mg/m2 Gyn103.03.2010 10:24:36
163336 Standard0Z51.100965 Docetaxel/doksorubicin109.03.2010 13:38:14
162879 Standard0Z51.100860 Dokso 50/Ifo5-SSG XX, inne >=70 år312.03.2009 15:12:14
162883 Standard0Z51.100858 Dokso 50/Ifo5-SSG XX, poli >=70 år312.03.2009 15:17:26
162885 Standard0Z51.100859 Dokso 60/Ifo6_SSG XX, poli <70 år112.03.2009 15:18:49
163086 Standard0Z51.100861 Dokso 60/Ifo6-SSG XX, inne <70 år326.06.2009 12:56:21
162847 Standard0Z51.100780 Dokso/ Ifosfamid - Euramos 1312.03.2009 10:53:51
162875 Standard0Z51.100724 Dokso50/Ifo5 - sarkom, 2dager212.03.2009 15:02:39
162805 Standard21Z51.100184 Doksorubicin105.03.2009 16:19:57
162876 Standard0Z51.100774 Doksorubicin - Euramos 1212.03.2009 15:05:28
162884 Standard0Z51.100696 Doksorubicin 75/4 timer112.03.2009 15:18:01
162874 Standard0Z51.100695 Doksorubicin 90/24 timer112.03.2009 14:59:21
163419 Studie211163 Doksorubicin Ixabepilone studien102.09.2011 16:13:21
162951 Standard0Z51.101070 Doxo Cyklo EPSSG 2005325.03.2009 16:18:00
162693 Standard0Z51.100098 Doxorubicin ukedose104.11.2008 15:56:59
163383 Standard21Z51.100114 DTIC107.12.2010 09:47:11
163218 Standard21Z51.100034 ECO126.01.2010 16:14:55
162176 Standard21Z51.100837 ECX epirubicin/cisplatin/xeloda2131.03.2008 10:39:45
162177 Standard21Z51.100838 ECX Epirubicin/Cisplatin/Xeloda dag1131.03.2008 11:04:52
162837 Standard0Z51.100740 EDP411.03.2009 13:58:32
161607 Standard21Z51.100026 ELF310.01.2006 14:43:20
162627gbk Standard0Z51.100729 EMA-CNS dag 1+2203.10.2008 13:24:19
162921 Standard0Z51.100156 EMA-CO813.03.2009 13:55:07
162629gbk Standard14Z51.100657 EMA-CO dag 1+2203.10.2008 13:27:52
162922 Standard0Z51.100886 EMA-CO dag 8 ca. testis113.03.2009 13:55:32
162526 Standard14Z51.100655 EMA-CO dag 8 trofoblast121.08.2008 13:53:45
162630gbk Standard0Z51.100538 EMA-EP dag 1+2202.10.2008 09:44:08
159892gbk Standard0Z51.100539 EMA-EP dag 8102.10.2008 09:46:26
162744 Standard21Z51.100068 ENAP518.12.2008 13:11:29
163268 Standard0Z51.121068 ENAP+rituximab, dag 1125.02.2010 09:46:43
162727 Standard0Z51.100890 ENAP+rituximab, dag 2-3301.12.2008 12:33:46
163468 Standard21Z51.100850 EOX Epirubicin/Oxaliplatin/Xeloda2120.05.2011 14:41:44
163467 Standard21Z51.100847 EOX Epirubicin/Oxaliplatin/Xeloda_d1120.05.2011 14:39:42
162828 Standard21Z51.100159 EP 5 dager511.03.2009 13:41:16
163436 Standard28Z51.100706 EP-GI305.04.2011 10:17:22
161130 Standard0Z51.100484 Epirubicin109.05.2005 13:27:15
159885 Standard0Z51.100726 Epirubicin ukedose122.01.2003 13:52:32
163125 Studie21Z51.100704 EPOCH-F502.10.2009 14:23:49
163474 Studie21Z51.100743 EPOCH-F/R512.08.2011 13:27:21
163530 Standard21Z51.101170 EPOCH-R517.02.2012 13:28:59
161835gbk Standard21Z51.100828 Eto 100 Ifo 1800, 3 dager328.11.2006 08:58:57
162366 Standard0Z51.100569 Eto1Ifo426.06.2008 09:21:08
162365 Standard0Z51.100566 Eto2Ifo2626.06.2008 09:09:56
162855 Standard0Z51.100694 Eto400/Dox75312.03.2009 12:38:23
163303 Standard21Z51.100827 Etoposid + Caelyx125.02.2010 11:01:57
162849 Standard0Z51.100781 Etoposid 500/ Ifosfamid 14000512.03.2009 10:54:56
160837 Standard28Z51.100467 Etoposid kapsler2109.03.2006 11:40:56
162792 Standard0Z51.101065 Etoposid-langerhanscellehistiocytose305.03.2009 14:31:47
161944 Standard0Z51.100836 Euro-LB 02 Induk 1A (Kreftklinikken)2616.09.2008 10:26:43
161943 Standard0Z51.100842 Euro-LB 02 Induk 1B (Kreftklinikken)2616.09.2008 10:49:51
162013 Standard0Z51.100856 Euro-LB 02 Reind 2A (Kreftklinikken)2229.04.2008 11:34:46
162657 Standard0Z51.100855 Euro-LB 02 Reind 2B (Kreftklinikken)1314.10.2008 10:33:18
160617EW Standard21Z51.100099 FAC 126.07.2005 14:41:52
162304 Standard0Z51.100930 Farmorubic/Omnipaque/Lipiodol-TACE111.03.2009 11:18:09
161718 Standard28Z51.100801 FCM328.03.2006 10:18:51
161423EW Standard0Z51.100702 FEC 100131.10.2005 15:11:15
161424EW Standard0Z51.100100 FEC 60131.10.2005 15:13:05
162952 Standard0Z51.100934 FLAG (AML residiv barn)625.03.2009 16:19:33
162953 Standard0Z51.100940 FLAG + DaunoXome, AML residiv barn625.03.2009 16:20:12
162433 Standard0Z51.100966 FLAG-Ida Kur 1522.07.2008 15:40:00
162434 Standard0Z51.100967 FLAG-Ida Kur 2522.07.2008 16:00:37
162266 Standard0Z51.100604 FLIRI229.04.2008 08:51:10
163293 Standard14Z51.110909 Fliri - Avastin225.02.2010 10:36:59
163466 Standard0Z51.100503 FLOX220.05.2011 14:38:24
163465 Standard14Z51.110910 Flox - Avastin220.05.2011 14:36:15
163464 Standard14Z51.100803 FLOX adjuvant220.05.2011 14:34:04
161431hhe Standard0Z51.100551 Fludarabin501.12.2005 16:11:05
161828hhe Standard28Z51.100707 FLUDARABIN/CYKLOFOSFAMID325.10.2006 08:38:43
163181 Standard0Z51.100874 Fluorouracil/streptozocin induksjon108.01.2010 08:17:48
162786 Standard0Z51.100013 FLv227.02.2009 16:05:07
160768 Studie14Z51.100607 Flv - de Gramont 229.07.2005 10:40:57
161257due Standard0Z51.100590 FLv - STRÅLE215.08.2005 13:45:33
163292 Standard14Z51.110907 Folfiri - Avastin125.02.2010 10:36:16
162272 Standard0Z51.100107 FuMi202.05.2008 13:02:41
159790due Standard0Z51.100020 FuMi-GI402.09.2005 11:11:14
161535hhe Standard28Z51.100313 GBOH-95; OPPA1513.12.2005 08:32:20
162188 Standard0Z51.100891 GemCap301.04.2008 09:27:33
163135 Standard0Z51.100783 GemCarbo dag 1103.12.2009 14:49:17
163141 Standard0Z51.100784 GemCarbo dag 8103.12.2009 14:39:23
162806 Standard21Z51.100709 GemCarbo GYN dag 1105.03.2009 16:20:22
162903 Standard0Z51.101092 Gem-Cis-Tax813.03.2009 11:04:51
161241raab Standard0Z51.100642 GEMCIT/CISPL- DAG 8 og DAG 15104.08.2005 10:34:38
161245raab Standard28Z51.100641 GEMCIT/CISPL, DAG 1-2304.08.2005 10:53:39
161244raab Standard0Z51.100749 GEMCIT/CISPL, DAG 1-3 nyresparende304.08.2005 10:31:18
161752 Standard28Z51.100399 Gemcitabin 109.05.2006 09:03:37
163087 Standard7Z51.100762 Gemcitabin 1000, mamma1501.07.2009 12:28:23
162899 Standard21Z51.100670 Gemcitabin 800 mg Dag 1 og 8812.03.2009 17:08:08
159914hhe Standard0Z51.100685 Gemcitabin Hodgkin1525.11.2005 08:22:15
163085 Standard0Z51.100792 Gemcitabin/ Docetaxl Sarkom, dag 1126.06.2009 10:54:53
163314 Standard0Z51.100793 Gemcitabin/Docetaxel Sarkom, dag 8125.02.2010 11:28:58
162087 Standard21Z51.100835 Gemcitabin/Vinorelbin, Hodgkin814.02.2008 08:36:22
161709hhe Standard28Z51.100306 GPOH-95; COPP1520.03.2006 08:48:45
161750hhe Studie21Z51.100309 GPOH-95; IEP 708.05.2006 14:41:07
160971hhe Standard28Z51.100310 GPOH-95; OEPA1502.12.2005 11:52:13
162654 Standard0Z51.100686 HAMMERSMITH -82 - MTX (dag 64-67 og 78-81)414.10.2008 08:50:09
161804 Standard0Z51.100211 HAMMERSMITH -82 RAT (43-48)612.02.2008 15:29:16
163225 Standard0Z51.100209 HAMMERSMITH -82 (1-29)2908.02.2010 09:27:14
161076hhe Standard0Z51.100591 HD - BuEC > 3 år (BFM 95)901.12.2005 16:28:15
161385hhe Standard0Z51.100758 HD MTX 1,5g > 60 år314.10.2005 14:02:54
161384hhe Standard0Z51.100757 HD MTX, 3 g514.10.2005 14:01:41
161332ksh Standard0Z51.100579 HD-BuM728.09.2005 09:17:25
162235 Standard0Z51.100906 HD-BuM - iv717.04.2008 12:50:40
162111 Standard0Z51.100614 HD-CYTARABIN (CNS-lymfom)307.03.2008 12:18:40
162664 Standard21Z51.100756 HD-CYTARABIN 4000, > 60 år214.10.2008 11:23:01
162779 Standard21Z51.100682 HD-CYTARABIN 6000 < 60 år202.02.2010 15:01:31
163270 Standard0Z51.121089 HD-CYTARABIN -RITUXIMAB MANTEL225.02.2010 09:52:39
163428 Standard0Z51.121090 HD-CYTARABIN-RITUXIMAB MANTEL 60-65 år214.03.2011 08:40:29
162857 Standard0Z51.100514 HDEC >16 år612.03.2009 12:39:15
162408 Standard0Z51.100962 Hemangioendotheliom 4 uk. vinkr uknt2228.07.2008 14:20:37
163343 Standard0Z51.110630 Herceptin hver 3 uke, 2. kur og senere113.04.2010 09:08:06
163253 Standard0Z51.120658 Herceptin hver 3. uke 1. kur125.02.2010 09:27:18
163427 Standard21Z51.120744 Herceptin Taxotere 3.uke, oppstart214.03.2011 08:39:43
163345 Standard21Z51.120745 Herceptin Taxotere 3.uke, vedlike113.04.2010 09:39:39
163284 Standard7Z51.110746 Herceptin Taxotere ukedose oppstart125.02.2010 10:28:59
163433 Standard7Z51.100747 Herceptin Taxotere ukedose vedlike114.03.2011 08:43:58
163489 Standard7Z51.100595 Herceptin ukent/Navelbine 2.kur+sen119.08.2011 14:40:33
163276 Standard0Z51.110505 Herceptin ukentlig 1. kur125.02.2010 10:01:12
161140 Standard0Z51.100506 Herceptin ukentlig 2. kur og senere110.05.2005 15:08:09
163278 Standard0Z51.110594 Herceptin ukentlig/Navelbine 1. kur225.02.2010 10:03:08
163261 Standard0Z51.120796 Herceptin/Navelbine 1.kur (Hernata)125.02.2010 09:38:53
163277 Standard0Z51.110592 Herceptin/Taxol (ukedose) 1. kur225.02.2010 10:02:13
163317 Standard7Z51.100593 Herceptin/Taxol 2. kur og senere103.03.2010 10:27:59
161748gbk Standard28Z51.100197 Hexametyl1408.05.2006 14:38:41
163099 Standard0Z51.100972 HIT 2000 CARBO/ETO (stPNET)319.08.2009 16:37:58
162955 Standard0Z51.100973 HIT 2000 CARBO/ETO + MTX it425.03.2009 17:07:59
162956 Standard0Z51.100974 HIT 2000 VCR/ MTX 5 gram (stPNET)425.03.2009 17:24:09
162957 Standard0Z51.100975 HIT 2000 VCR/ MTX 5 gram + MTX it425.03.2009 17:25:00
162958 Standard0Z51.100976 HIT 2000 VCR/CYK (stPNET)425.03.2009 17:25:29
162959 Standard0Z51.100977 HIT 2000 VCR/CYK + MTX it425.03.2009 17:25:57
162451 Standard0Z51.100978 HLH Eto124.07.2008 14:24:42
162665 Standard21Z51.100768 Hyper CVAD-Mtx/araC < 60år714.10.2008 12:28:22
162666 Standard21Z51.100738 Hyper-CVAD Cyclo1114.10.2008 12:45:32
162960 Standard0Z51.100979 Høydose Ara-C NOPHO-ALL425.03.2009 17:27:21
162961 Standard0Z51.100980 Høydose BUMEL827.03.2009 10:55:27
162962 Standard0Z51.100981 Høydose BUMEL vekt <12 kg827.03.2009 10:55:54
162963 Standard0Z51.100982 Høydose CEM MAT gfr<100827.03.2009 10:58:08
162964 Standard0Z51.100983 Høydose CEM MAT gfr<100 vekt<12 kg827.03.2009 11:05:59
162965 Standard0Z51.100984 Høydose CEM MAT gfr>100827.03.2009 11:06:26
162966 Standard0Z51.100985 Høydose CEM MAT gfr>100 vekt<12 kg827.03.2009 11:07:00
161156hhe Standard0Z51.100002 HØYDOSE CYKLOFOSFAMID (v/TBI)201.12.2005 13:35:06
162841 Standard21Z51.100512 Høydose Ifosfamid 15g/m2611.03.2009 14:26:02
162840 Standard0Z51.100510 Høydose Ifosfamid-10g/m2611.03.2009 14:25:20
162839 Standard0Z51.100619 Høydose Ifosfamid-12g/m2611.03.2009 14:24:46
161536hhe Standard0Z51.100688 Høydose Melphalan102.12.2005 12:45:50
162466 Standard0Z51.100069 Høydose mtx 2g/kvm125.07.2008 11:17:38
162967 Standard0Z51.100986 Høydose MTX 5 gram NOPHO-ALL427.03.2009 11:07:34
162968 Standard0Z51.100987 Høydose MTX 8 gram NOPHO-ALL427.03.2009 11:08:29
162969 Standard0Z51.100988 Høydose MTX ekstraark NOPHO-ALL227.03.2009 11:10:39
162915 Standard0Z51.100509 HØYDOSE VIP513.03.2009 13:52:04
162970 Standard0Z51.100989 Idarubicin 5 mg/m2 enkeltdose127.03.2009 11:20:45
163226 Standard0Z51.101128 IEP EuroNet-PHL-C1504.06.2010 13:34:58
162850 Standard0Z51.100678 Ifo/Adm 312.03.2009 10:55:19
162848 Standard0Z51.100680 Ifo/CDP412.03.2009 10:54:28
162854 Standard0Z51.100775 Ifo/CDP-Euroboss 1 V/ hørselsproblemer512.03.2009 12:37:53
162971 Standard0Z51.101069 IfoDoxo EPSSG NRSTS 2005327.03.2009 11:32:26
162823 Standard21Z51.100787 Ifosfamid 4500 Paclitaxel 175311.03.2009 12:49:59
162636gbk Standard21Z51.100804 Ifosfamid single303.10.2008 12:36:05
163110 Standard21Z51.100846 IGEV Hodgkin407.09.2009 11:16:03
163105 Standard0Z51.100586 IKE301.09.2009 11:19:09
162729 Standard0Z51.100917 IKE+rituximab301.12.2008 13:14:29
163297 Standard0Z51.111058 IKE+rituximab, dag 1125.02.2010 10:41:51
163334 Standard0Z51.101059 IKE+rituximab, dag 2-3309.03.2010 13:35:56
163209 Standard21Z51.101124 IME516.04.2010 11:07:39
163234 Standard0Z51.101127 IME dag 2-5512.02.2010 15:51:22
163274 Standard0Z51.121126 IME-rituximab dag 1125.02.2010 09:58:46
163233 Standard0Z51.101123 IME-rituximab, hele kuren512.02.2010 15:49:43
162972 Standard0Z51.100990 Ind 1 dag 01 NOPHO-ALL127.03.2009 12:31:05
162973 Standard0Z51.100991 Ind 1 dag 08, 15 og 29 NOPHO-ALL127.03.2009 12:34:08
162974 Standard0Z51.100992 Ind 1 dag 22 NOPHO-ALL127.03.2009 12:34:40
162975 Standard0Z51.100993 Ind 1 dag 36 I/VI/EI NOPHO-ALL127.03.2009 12:51:51
162976 Standard0Z51.101027 Ind 1 dag 36 SI / II NOPHO-ALL127.03.2009 13:11:46
162977 Standard0Z51.100995 Ind 1 dag 40, 43 og 47 NOPHO-ALL127.03.2009 13:21:19
162978 Standard0Z51.100996 Ind. 1A dag 08 og 29 EURO-LB 02127.03.2009 13:45:49
162979 Standard0Z51.100997 Ind. 1A dag 15 EURO-LB 02127.03.2009 14:04:38
162980 Standard0Z51.100998 Ind. 1A dag 22 EURO-LB 02127.03.2009 14:05:27
162981 Standard0Z51.100999 Ind. 1A l-asp alene EURO-LB 02127.03.2009 14:06:17
162982 Standard0Z51.101000 Ind. 1B cytarabin 4 d. EURO-LB 02427.03.2009 14:17:27
162983 Standard0Z51.101001 Ind. 1B cytarabin, bare 1 dag127.03.2009 14:49:32
162984 Standard0Z51.101002 Ind. 1B dag 36 Cyk EURO-LB 02127.03.2009 14:50:05
162985 Standard0Z51.101003 Ind. 1B dag 64 Cyk EURO-LB 02127.03.2009 14:51:08
162570 Standard0Z51.100896 Ind. M EURO LB 02_11116.09.2008 11:18:17
162588 Standard0Z51.100916 Ind. M EURO LB 02_2 (fra dag 22,36, 50)416.09.2008 14:32:02
163359Halfdan Standard28Z51.101132 Ipstyl104.06.2010 12:43:58
163257 Standard0Z51.120698 Irinotecan+Cetuximab < 70 år, 1 kur125.02.2010 09:31:56
163281 Standard21Z51.110731 Irinotecan+Cetuximab <70 årvedlike125.02.2010 10:24:12
163283 Standard21Z51.110734 Irinotecan+Cetuximab >70 år vedlike125.02.2010 10:26:14
161873 Standard0Z51.120732 Irinotecan+Cetuximab >70år, 1.kur118.01.2007 08:11:24
163288 Standard21Z51.110773 Irinotecan+Cetuximab >70år, 3. uke125.02.2010 10:33:18
163429 Standard14Z51.121145 Irinotecan+panitumumab114.03.2011 08:41:11
163439 Standard21Z51.101165 Irinotekan (Campto) 113.05.2011 13:27:32
163440 Standard21Z51.101166 IRIS (Carboplatin+Campto)120.05.2011 14:13:25
162986 Standard0Z51.101004 ISG/SSG III & IV CEto Barn427.03.2009 14:51:36
162987 Standard0Z51.101005 ISG/SSG III & IV VAdmC Barn227.03.2009 14:58:34
162988 Standard0Z51.101006 ISG/SSG III Eto1Ifo Barn427.03.2009 14:59:45
162989 Standard0Z51.101007 ISG/SSG III VIfoAct Barn427.03.2009 15:02:09
162990 Standard0Z51.101008 ISG/SSG IV Eto2Ifo2 Barn627.03.2009 15:02:30
162991 Standard0Z51.101009 ISG/SSG IV VAdmIfo Barn327.03.2009 15:02:55
162992 Standard0Z51.101071 IVA 9 gram MMT 98327.03.2009 15:03:24
162993 Standard0Z51.101072 IVA EPSSG 2005227.03.2009 15:03:52
162861 Standard21Z51.100811 IVA - MMT 95212.03.2009 12:52:51
162994 Standard0Z51.101039 IVADo EPSSG 2005227.03.2009 15:05:50
162995 Standard0Z51.101040 IVADo EPSSG 2005 >= 15 år227.03.2009 15:06:18
162996 Standard0Z51.101073 IVADo <1 år <=10 kg EPSSG 2005227.03.2009 15:06:44
162997 Standard0Z51.101074 IVE MMT 98327.03.2009 15:07:10
163452 Standard21Z51.101146 Ixabepilone studie endometrie116.05.2011 08:09:25
160638hhe Standard0Z51.100124 Ixotene (Trofosfamid)101.12.2005 15:08:35
162998 Standard0Z51.101010 JEB germinom327.03.2009 15:09:20
163453 Standard21Z51.101154 Karbo - Paklitaxel Hypersens116.05.2011 08:09:59
163454 Standard21Z51.101156 Karbo/Caelyx 30 Hypersens116.05.2011 08:10:29
163455 Standard21Z51.101155 Karbo/Epirubicin Hypersens116.05.2011 08:10:59
163456 Standard21Z51.101153 Karbo/Gemcitabin Hypersens116.05.2011 08:11:28
163457 Standard21Z51.101142 Karbo-Fu Neores516.05.2011 08:11:55
163458 Standard21Z51.101147 Karboplatin - Paklitaxel OCTAVIA116.05.2011 08:12:26
163459 Standard21Z51.101149 Karboplatin - Paklitaxel OVAR 12116.05.2011 08:13:20
162999 Standard0Z51.101011 Konsolidering Ara-C (SI/II) NOPHO-ALL427.03.2009 15:11:22
163000 Standard0Z51.100945 Konsolidering høy intens AML residiv527.03.2009 15:11:51
163001 Standard0Z51.100926 Konsolidering lav intensitet AMLresidiv427.03.2009 15:12:16
162525 Standard21Z51.101033 Lapatinib - Capecitabine507.11.2008 12:21:11
162794 Standard0Z51.101012 LCH-III Vinblastin105.03.2009 14:38:31
162795 Standard0Z51.101013 LCH-III Vinblastin/MTX 0,5 gram305.03.2009 14:42:01
161542hhe Standard28Z51.100599 Leukeran, syklisk 502.12.2005 14:23:51
161559hhe Standard1Z51.100071 Leukeran/Prednison 106.12.2005 10:28:19
161610 Standard5Z51.100790 Leustatin514.03.2006 08:52:18
163002 Standard0Z51.100922 Lille BuCy allogen stamcelletx barn227.03.2009 15:19:31
160688hhe Standard28Z51.100433 LOPP 1402.12.2005 11:16:16
163003 Standard0Z51.101014 LSA2L2 kur 1 (I/VI/EI) Bare dag 5!127.03.2009 16:03:33
163004 Standard0Z51.101015 LSA2L2 kur 1 (I/VI/EI) NOPHO-ALL527.03.2009 16:04:03
163005 Standard0Z51.101016 LSA2L2 kur2 (I/VI/EI) Bare dag 5!127.03.2009 16:04:42
163006 Standard0Z51.101017 LSA2L2 kur2 (I/VI/EI) NOPHO-ALL527.03.2009 16:05:10
163007 Standard0Z51.101018 LSA2L2 kur3 (I/VI/EI) Bare dag 5!127.03.2009 16:05:39
163008 Standard0Z51.101019 LSA2L2 kur3 (I/VI/EI) NOPHO-ALL527.03.2009 16:06:09
163009 Standard0Z51.101020 LSA2L2 kur4 (I/VI/EI) NOPHO-ALL527.03.2009 16:06:32
161508hhe Standard28Z51.100054 LVPP / hele kuren 1425.11.2005 11:26:15
163350 Standard0Z51.100869 LVPP dag 1, barn106.05.2010 13:42:19
163011 Standard0Z51.101021 LVPP dag 8, barn127.03.2009 16:07:30
163194 Standard56Z51.100056 LVPP-mini / hele kuren 1504.06.2010 13:15:00
161982 Standard0Z51.100549 MAXI-CHOP103.10.2007 10:54:23
163265 Studie0Z51.120889 MAXI-CHOP-rituximab Nordisk MCL III125.02.2010 09:42:40
160898 Standard42Z51.100256 Melfalan-Prednisolon413.12.2005 12:26:21
162614 Standard0Z51.100436 Methotreksat intrathekalt 12mg122.09.2008 10:51:13
162632gbk Standard11Z51.100186 Methotreksat lavdose402.10.2008 10:06:18
161044 Standard0Z51.100405 Metotrexat intrathekalt 10mg125.08.2005 10:19:16
161501hhe Standard0Z51.100489 Metotrexat intrathekalt 15mg102.12.2005 13:35:50
161560raab Standard21Z51.100634 Mitoksantron / Prednison106.12.2005 10:35:36
161932 Standard21Z51.100625 Mitoksantron og Prednisolon127.02.2007 14:02:37
162807 Standard14Z51.100200 Mitoxantron-Intraperitonealt105.03.2009 16:32:46
162808 Standard28Z51.100201 Mitoxantron-Intrapleuralt105.03.2009 16:35:31
163012 Standard0Z51.100943 ML DS 2007 kur haM < 1 år / 12 kg427.03.2009 16:08:33
163082 Standard0Z51.100119 MTX - Euramos 1324.06.2009 12:58:21
163083 Standard0Z51.100679 MTX - Euroboss 1424.06.2009 14:16:18
161502gbk Standard0Z51.100713 MTX intrathecal Gyn102.10.2008 10:02:10
159809Evensen Standard0Z51.100176 MTX ukedose127.05.2005 15:07:08
161546hhe Standard0Z51.100616 MTX-CNS-lymfom420.11.2006 11:52:17
163528 Standard14Z51.101171 MTX-R-CHOD-CHIC > 60 1. kur403.02.2012 13:47:13
163529 Standard14Z51.101172 MTX-R-CHOP-CHIC 1. KUR403.02.2012 13:48:55
161393 Standard0Z51.100171 M-VAC (dag 1-2)324.10.2005 10:12:23
159814raab Standard0Z51.100172 M-VAC (dag 15+22)804.08.2005 11:20:45
161394 Standard28Z51.100170 M-VAC (hele)2224.10.2005 10:13:30
162212 Standard21Z51.100617 Navelbine 25 mg/m2110.04.2008 14:24:05
163377 Standard21Z51.100779 Navelbine adjuvant dag 8129.10.2010 11:27:25
161945 Standard0Z51.100849 Naxogin 1 dag124.08.2007 15:09:24
159864 Standard0Z51.100652 NOPHO - HD Mtx 8g416.11.2002 16:35:50
163013 Standard0Z51.100919 NOPHO-AML kur AIET >1år >10 kg627.03.2009 16:09:00
163014 Standard0Z51.100923 NOPHO-AML kur AIET infant / <10 kg627.03.2009 16:09:37
163015 Standard0Z51.100935 NOPHO-AML kur AM >1år >10 kg627.03.2009 16:10:06
163016 Standard0Z51.100946 NOPHO-AML kur AM infant / <10 kg627.03.2009 16:10:33
163017 Standard0Z51.100918 NOPHO-AML kur HA1M >1år >10 kg527.03.2009 16:10:56
163018 Standard0Z51.100921 NOPHO-AML kur HA1M infant /<10kg527.03.2009 16:11:27
163019 Standard0Z51.100925 NOPHO-AML kur HA2E >1år >10 kg527.03.2009 16:17:07
163020 Standard0Z51.100944 NOPHO-AML kur HA2E infant / <10 kg527.03.2009 16:17:29
163021 Standard0Z51.100920 NOPHO-AML kur HA3 infant / <10kg427.03.2009 16:17:55
163022 Standard0Z51.100851 NOPHO-AML kur HA3 >1 år >10 kg427.03.2009 16:18:17
162669 Standard21Z51.100651 NOPHO-HD-Cytarabin514.10.2008 13:58:22
162571 Studie0Z51.100863 Nordisk PCNSL blokk A1 66 år og over516.09.2008 12:31:24
162591 Studie0Z51.100899 Nordisk PCNSL blokk A1 under 66518.09.2008 10:26:58
162592 Studie0Z51.100868 Nordisk PCNSL blokk A2 under 66518.09.2008 10:29:43
162593 Studie0Z51.100902 Nordisk PCNSL blokk B1-A2-B2 _66 år og over618.09.2008 10:32:16
162572 Studie0Z51.100854 Nordisk PCNSL blokk B1-B2 under 66516.09.2008 12:42:24
162219 Studie0Z51.100903 Nordisk PCNSL blokk C1-C2 over 65324.04.2008 15:52:38
162253 Studie0Z51.100915 Nordisk PCNSL blokk C1-C2 under 66324.04.2008 14:29:24
161518hhe Standard28Z51.100312 OEPA (DAG 15)120.03.2006 10:23:23
163104 Standard28Z51.100311 OEPA (DAG 1-8)831.08.2009 16:16:42
163023 Standard0Z51.101022 OEPA dag 1 Barn127.03.2009 16:19:01
163024 Standard0Z51.101023 OEPA dag 1 EuroNet-PHL-C1 Barn127.03.2009 16:19:54
163025 Standard0Z51.101025 OEPA dag 15 Barn127.03.2009 16:20:25
163026 Standard0Z51.101026 OEPA dag 2-5 EuroNet-PHL-C1 Barn427.03.2009 16:20:51
163027 Standard0Z51.101028 OEPA dag 3-6 Barn427.03.2009 16:21:13
163028 Standard0Z51.101029 OEPA dag 8 Barn127.03.2009 16:21:38
163326 Studie0Z51.100897 OEPA EURONET-PHL-C1 (DAG 15)109.03.2010 13:19:07
162205 Studie0Z51.100898 OEPA EURONET-PHL-C1 (DAG 1-8)819.12.2008 12:52:43
162914 Studie28Z51.100818 OI-testis1513.03.2009 13:50:11
162906 Studie28Z51.100820 OI-testis dag 8113.03.2009 13:08:02
160686hhe Standard21Z51.100420 OPAL (residiv/eldre) 618.01.2006 07:47:26
161746hhe Standard28Z51.100314 OPPA (DAG 15)104.05.2006 14:43:06
161745hhe Standard28Z51.100315 OPPA (DAG 8)104.05.2006 14:39:23
163029 Standard0Z51.101030 OPPA dag 1 Barn127.03.2009 16:22:05
163030 Standard0Z51.101031 OPPA dag 15 Barn127.03.2009 16:22:32
163031 Standard0Z51.101032 OPPA dag 8 Barn127.03.2009 16:24:53
163372 Standard21Z51.101141 Oxali-Fu NeoRes503.09.2010 13:08:03
162913 Studie28Z51.100819 Oxaliplatin - Irinotekan dag 1 og 15113.03.2009 13:49:50
162809 Standard21Z51.100826 Oxaliplatin 130105.03.2009 16:37:19
162180 Studie7Z51.100735 Oxaliplatin-stråle131.03.2008 12:48:29
162810 Standard21Z51.100807 Paclical105.03.2009 16:59:46
162811 Standard21Z51.100203 Paclitaxel105.03.2009 17:11:58
163384 Standard21Z51.100531 Paclitaxel - Carboplatin107.12.2010 09:47:42
162308 Standard21Z51.100485 Paclitaxel - Carboplatin (vesica)120.05.2008 14:15:59
162813 Standard21Z51.100654 Paclitaxel 24 t + Carboplatin205.03.2009 17:13:40
163460 Standard21Z51.101148 Paclitaxel dag 8 og 15 OCTAVIA116.05.2011 08:13:48
163418 Studie21Z51.101162 Paclitaxel Ixabepilone studien102.09.2011 16:12:06
162900 Standard0Z51.100588 Paclitaxel/Gemcitabine Gyn112.03.2009 17:08:53
162902 Standard0Z51.100618 Paclitaxel-Gemcitabin113.03.2009 11:04:17
162866 Standard0Z51.100126 PAI512.03.2009 13:19:31
163461 Standard0Z51.101144 Paklitaxel/etopsoid/carboplatin416.05.2011 08:14:18
163431 Standard21Z51.111159 Paklitaxel/Topotecan cervix314.03.2011 08:42:43
163363 Standard14Z51.121121 Panitumumab111.06.2010 13:33:14
161694 Standard0Z51.100710 PC/PE Dag 1 Gyn103.03.2006 12:20:21
161695gbk Standard0Z51.100711 PC/PE Dag 15 Gyn102.10.2008 13:06:48
163142 Standard0Z51.100011 PCV103.12.2009 14:41:05
162905 Standard21Z51.100161 PEI 513.03.2009 13:07:05
163319 Standard21Z51.100496 PIFL203.03.2010 10:30:44
160741hhe Standard0Z51.100550 PRECORTALON 102.12.2005 14:03:51
163527 Studie0Z51.101169 Prefase_CHIC503.02.2012 13:41:58
162440 Standard0Z51.100970 Promyelocyttleukemi, Induksjon724.07.2008 10:57:03
162438 Standard0Z51.100968 Promyelocyttleukemi, Konsolidering 1724.07.2008 09:54:31
162439 Standard0Z51.100969 Promyelocyttleukemi, Konsolidering 2424.07.2008 10:02:33
163032 Standard0Z51.101034 Protocol M: MTX 5 gram EURO-LB 02427.03.2009 16:25:17
163136 Standard0Z51.100782 PV - 3 dager iv303.12.2009 16:12:48
163138 Standard0Z51.100035 PV - standard403.12.2009 16:10:00
163423 Standard0Z51.131035 RALLE A1 NOPHO-ALL residiv114.03.2011 08:37:05
163295 Standard0Z51.111036 RALLE A2 NOPHO-ALL residiv125.02.2010 10:39:57
163035 Standard0Z51.101081 RALLE res u4 NOPHO-ALL residiv127.03.2009 16:29:07
163036 Standard0Z51.101082 RALLE res u5 NOPHO-ALL residiv127.03.2009 16:29:45
163037 Standard0Z51.101077 RALLE resp C2 araC NOPHO-ALL res427.03.2009 16:30:18
163422 Standard0Z51.131079 RALLE resp u2 (A3) NOPHO-ALL res114.03.2011 08:35:45
163425 Standard0Z51.131080 RALLE resp u3 (A4) NOPHO-ALL res114.03.2011 08:38:25
163324 Standard0Z51.101093 RALLE sen intens u3 NOPHO-ALL res109.03.2010 13:17:25
163424 Standard0Z51.131083 RALLE senintens u0 NOPHO-ALL res114.03.2011 08:37:44
163322 Standard0Z51.101103 Re-ind II/b AraC d 38, 45 EURO LB 02109.03.2010 12:53:30
163331 Standard0Z51.101096 Re-ind. II/a dag 8 og 15 EURO-LB 02109.03.2010 13:33:36
163495 Standard0Z51.110464 Rituximab110.11.2011 10:02:57
162746 Standard28Z51.100621 RITUXIMAB-FCM418.12.2008 13:54:55
163235 Standard0Z51.101125 Rituximab-Fludara-Cyklof. dag 2-3312.02.2010 15:51:53
163228 Standard0Z51.101091 Rituximab-Fludara-Cyklofosfamid309.02.2010 14:08:24
163273 Standard0Z51.121122 Rituximab-Fludara-Cyklofosfamid d.1125.02.2010 09:57:47
163250 Standard0Z51.130839 Rituximab-Zevalin standard825.02.2010 09:21:43
163249 Studie0Z51.130791 Rituximab-Zevalin studie125.02.2010 09:14:55
163432 Standard28Z51.101134 Sandostatin LAR114.03.2011 08:43:20
163077 Standard0Z51.101112 Sen int. interm. Ara-C NOPHO-ALL414.07.2009 13:08:02
163078 Standard0Z51.101113 Sen int. interm. cyklofos NOPHO-ALL114.07.2009 13:07:04
163328 Standard0Z51.101115 Sen int. interm. d04/11 NOPHO-ALL109.03.2010 13:27:17
163332 Standard0Z51.101109 Sen intensiv. (I/VI) d08 NOPHO-ALL109.03.2010 13:34:29
163323 Standard0Z51.101111 Sen intensiv. (I/VI) d22 NOPHO-ALL109.03.2010 12:54:36
163333 Standard0Z51.101114 Sen intensiv. interm. d01 NOPHO-ALL109.03.2010 13:35:21
162549 Standard0Z51.101047 SIOP PNET4 Dag 1102.09.2008 13:50:43
162101 Standard0Z51.100870 Streptozocin/ mitotane vedlikehold110.03.2008 13:02:57
163185 Standard0Z51.100872 Streptozocin/mitotane induksjon329.01.2010 13:01:26
161854 Studie42Z51.100824 SUTENT, 1 dag102.01.2007 12:45:49
161855 Studie42Z51.100823 SUTENT, hele kuren2802.01.2007 12:45:33
163437 Standard7Z51.100601 Taxol ukentlig - 80 - 90 mg/m2102.05.2011 08:15:39
163312 Standard0Z51.100112 Taxotere 100 hver 3. uke (mammae)125.02.2010 11:26:41
163301 Standard21Z51.100548 Taxotere 75 mg/m2-2 linje behandling125.02.2010 10:59:53
163169 Standard7Z51.100040 Taxotere ukedose 20 mg/m2124.11.2009 14:26:46
161846 Standard7Z51.100659 Taxotere ukedose, 30 mg/m2101.12.2006 11:17:23
161341 Standard7Z51.100628 Taxotere ukedose, 35 mg/m2128.09.2005 14:35:54
163335 Standard0Z51.101063 Taxotere-cyklof hver 3.uke -mammae109.03.2010 13:37:19
162641gbk Standard21Z51.100808 TCG dag 1 Trofoblast106.10.2008 16:37:54
162814 Standard21Z51.100540 TEC105.03.2009 17:14:25
163385 Standard28Z51.100587 Temodal507.12.2010 09:48:22
163143 Standard42Z51.100822 Temodal 75 mg/m2103.12.2009 14:47:46
162306 Standard0Z51.100931 Temsirolimus (Torisel)115.09.2008 11:06:50
162909 Standard0Z51.100495 TIP513.03.2009 13:23:04
160710due Standard21Z51.100466 Tomudex 115.08.2005 13:35:06
162815 Standard21Z51.100534 Topotecan505.03.2009 17:14:47
160850gbk Standard0Z51.100653 Topotecan 5 dager511.08.2005 15:14:47
163321 Standard0Z51.101057 Topotecan ukentlig103.03.2010 10:32:42
162194 Standard0Z51.100894 TPF ØNH529.04.2008 12:19:12
162648 Standard0Z51.100643 Trippel intrathecal113.10.2008 10:54:24
163041 Standard0Z51.100867 TVD nevroblastom627.03.2009 16:43:52
163042 Standard0Z51.101075 VA EPSSG 2005127.03.2009 16:44:21
163043 Standard0Z51.101076 VA <1 år <=10 kg EPSSG 2005127.03.2009 16:44:53
163230 Standard21Z51.101130 VAC Euro Ewing voksne218.02.2011 13:31:38
160899hhe Standard28Z51.100258 VAD 413.12.2005 09:00:51
162368 Standard0Z51.100568 VAdm1Ifo1326.06.2008 10:14:37
162367 Standard0Z51.100570 VAdm2C2226.06.2008 09:35:10
162361 Standard0Z51.100564 VAdmC1224.06.2008 12:40:58
162869 Standard0Z51.100127 VAI512.03.2009 13:21:32
160900 Standard28Z51.100259 VBAP 113.12.2005 11:52:30
163048 Standard0Z51.101095 Vcr/ Cisplatin LGG 2004 < 10 kg330.04.2009 14:58:31
163327 Standard0Z51.101094 Vcr/Cyk UKCCSG CNS9204 Baby brain209.03.2010 13:26:37
160697 Standard0Z51.100447 VEC 314.10.2005 10:26:16
162918 Standard0Z51.100437 VeIP513.03.2009 13:53:24
163386 Standard7Z51.101118 Velbe107.12.2010 09:48:52
160711hhe Standard0Z51.100470 Velbe-prednisolon128.11.2005 14:21:32
162844 Standard0Z51.100128 VI311.03.2009 14:29:16
163187 Standard28Z51.101120 VIDAZA723.02.2010 08:47:07
162362 Standard0Z51.100565 VIfoAct424.06.2008 12:58:53
162843 Standard0Z51.100129 VIG311.03.2009 14:27:47
163426 Standard21Z51.131138 Vinflunine114.03.2011 08:39:04
161043 Standard0Z51.100404 Vinkristin 118.10.2005 10:06:09
163096 Standard7Z51.100571 Vinkristin 1,5 mg/m2119.08.2009 14:17:14
163507 Standard0Z51.101129 Vinkristin vorfase FLYER109.12.2011 12:51:29
162908 Standard0Z51.100163 VIP513.03.2009 13:15:16
163242 Standard0Z51.100521 VORPHASE, GMALL -02523.02.2010 09:40:59
162183 Standard21Z51.100596 Xeloda 1431.03.2008 13:20:15
162782 Standard7Z51.100763 Xeloda - Taxol ukedose112.02.2009 15:12:04
161348 Standard21Z51.110769 Xeloda - Taxotere hver 3. uke122.02.2006 11:48:43
162184 Standard21Z51.100666 Xelox (oxaliplatin-capecitabine)1431.03.2008 13:29:03
162185 Standard21Z51.100667 Xelox (oxaliplatin-capecitabine) dag1131.03.2008 13:29:43
162881 Standard0Z51.130857 Yondelis112.03.2009 15:13:34
162564 Studie0Z51.101051 Zalutumomab-Cisplatin - DAHANCA 19112.09.2008 14:14:48
162565 Studie0Z51.101050 Zalutumumab DAHANCA 19112.09.2008 14:15:04
162668 Standard0Z51.100580 AA-24 > 3år (BFM 95)514.10.2008 13:56:38
kur_idZkodeKurdefinisjonSist_oppdatertAntall_Dager
0023 Z51.105FU / Streptozocin vedlikehold09.03.20101
0185 Z51.105FU/Follinat05.03.20092
0848 Z51.105-FU/Streptozocin over 2dg vedlike08.01.20102
0751 Z51.10ABR-21762029.11.20053
0453 Z51.10ABVD / hele kuren 03.03.201015
0304 Z51.10ABVD dag 1 og 1528.08.20091
0448 Z51.10ABVP26.01.200614
0033 Z51.10ACO 04.12.20061
0511 Z51.10AdriaHoloxanIntensivert05.03.20094
0528 Z51.10AdriaHoloxanSSG1305.03.20092
0660 Z51.12ALIMTA + Cisplatin07.12.20101
0663 Z51.12Alimta 500mg/m207.12.20101
0750 Z51.12Alimta 500mg/m2 lunge25.02.20101
0692 Z51.12Alimta-Carboplatin, mesotheliom07.12.20101
0866 Z51.10ALL Induksjon Hammersmith RAT16.09.20085
0963 Z51.10ALL, AML - MTX intrathekal 15 mg18.09.20081
0226 Z51.10ALL, Vedlikehold syklus 10-1307.03.200815
0971 Z51.10AlloTx Liten BuCy16.09.200820
0876 Z51.10ALL-REZ BFM 2002 block F120.03.20096
0877 Z51.10ALL-REZ BFM 2002 block F220.03.20095
0878 Z51.10ALL-REZ BFM 2002 block R120.03.20096
0879 Z51.10ALL-REZ BFM 2002 block R220.03.20096
0239 Z51.10AML Høydose Cytarabin Konsolidering01.07.20083
0228 Z51.10AML Induksjon (3/7) < 60 år RH30.06.20083
0232 Z51.10AML Induksjon 3 M5A5E5 < 60 år RH30.06.20085
0230 Z51.10AML Induksjon II, 2(2/5) <60 år RH30.06.20083
0236 Z51.10AML Konsolidering I N3A5 < 60 år RH01.07.20082
0238 Z51.10AML Konsolidering II M3A5E3 <60 RH 24.11.20082
1157 Z51.10Avastin Aurelia hver 14. dag16.05.20111
1150 Z51.10Avastin Aurelia hver 3. uke16.05.20111
0733 Z51.11Avastin hver 14. dag25.02.20101
1042 Z51.12Avastin hver 14. dag, ca. renis25.02.20101
0765 Z51.11Avastin hver 3. uke19.08.20111
0852 Z51.10Avastin hver 3. uke ICON719.08.20111
1158 Z51.10Avastin hver 3. uke OCTAVIA16.05.20111
0875 Z51.10AVD (Velcade)09.12.201111
0047 Z51.10AVOP/ hele kuren 04.06.201014
0557 Z51.10BEACOPP- doseeskalert (dag 1-3)24.03.20103
0558 Z51.10BEACOPP- doseeskalert (dag 8)22.03.20101
0473 Z51.10BEACOPP- standard (dag 1-3)24.03.20103
0474 Z51.10BEACOPP- standard (dag 8)25.05.20091
0472 Z51.10BEACOPP standard hele kuren16.12.20118
0003 Z51.10BEAM_etopofos16.02.20105
1049 Z51.11Bendamustine (Ribomustin)25.02.20102
1048 Z51.13Bendamustine (Ribomustin)-rituximab25.02.20102
0138 Z51.10BEP, hele kuren13.03.200915
0139 Z51.10BEP-5 dager13.03.20095
0141 Z51.10BEP-Ifosfamid / hele kuren 13.03.200915
0142 Z51.10BEP-Ifosfamid /del A 13.03.20095
0143 Z51.10BEP-Ifosfamid /del B (Bleo dag 15 )13.03.20091
0140 Z51.10Bleo Dag 1513.03.20091
1064 Z51.10Bleomycin intrapleuralt01.12.20081
0880 Z51.10Block R1-modif NOPHO-ALL residiv25.03.20093
0881 Z51.10Block R2-modif NOPHO-ALL residiv25.03.20095
0522 Z51.10Blokk A < 55 år14.10.20085
0547 Z51.10Blokk B <55 år, GMALL0223.02.20105
0524 Z51.10Blokk B1>55 årMTX 0,5g/m2GMALL0223.02.20105
0529 Z51.10Blokk B2>55 MTX 1,5g/m2, GMALL0223.02.20105
0525 Z51.10Blokk C uten rituximab BFM22.02.20105
1131 Z51.10Blokk C< 55 år, GMALL0202.12.20115
0681 Z51.10Blokk CC13.10.20085
0523 Z51.10BlokkA1>55 -MTX 0,5g/m2,GMALL0220.04.20105
0552 Z51.10BlokkA2>55 MTX 1,5g/m2, GMALL0223.02.20105
0883 Z51.10B-NHL BFM 04 Kur A24 (mediastinal)25.03.20097
0882 Z51.10B-NHL BFM 04 Kur A425.03.20097
0884 Z51.10B-NHL BFM 04 Kur B24 (mediastinal)25.03.20097
0885 Z51.10B-NHL BFM 04 Kur B425.03.20097
0947 Z51.10B-NHL BFM 04 Kur BB2425.03.20097
0948 Z51.10B-NHL BFM 04 Kur CC25.03.20095
0949 Z51.10B-NHL BFM 04 Kur AA2425.03.20097
0950 Z51.10B-NHL BFM 04 Vorfase V25.03.20093
0951 Z51.10B-NHL BFM 04 Vorfase VZ25.03.20093
0091 Z51.10BOP (dag 1, 8)26.01.20091
0092 Z51.10BOP (dag 15, 22)22.03.20061
0090 Z51.10BOP/ hele kuren 22.03.200622
0794 Z51.11Bortezomid/ Dexametason 2 dager23.11.20112
0994 Z51.10BUMEL melfalanbestilling barn25.03.20091
0572 Z51.10C1Eto117.06.20084
0567 Z51.10C2Eto217.06.20084
1168 Z51.13Cabazitaxel10.08.20111
0952 Z51.10CADO nevroblastom25.03.20095
0576 Z51.10Caelyx25.02.20101
0640 Z51.10Caelyx og Streptozotocin vedlikehold25.02.20101
0635 Z51.10Caelyx-Kaposi 03.03.20101
0639 Z51.10Caelyx-Streptozotocin induksjonskur08.01.20105
1152 Z51.13Caleyx Trabectidine14.03.20111
0645 Z51.10CAMPATH-1H10.03.20081
0904 Z51.10CAMPATH-1H, subcutan29.04.20081
0644 Z51.10CAMPATH-1H-oppstart10.03.20083
0012 Z51.10Campto15.08.20051
0932 Z51.10Campto- EMR (over 70 år)22.05.20081
0929 Z51.10CAP - sarkom09.03.20101
0964 Z51.10Capecitabine po21.08.200814
0813 Z51.10Capecitabine stråle31.03.20085
0812 Z51.10Capecitabine stråle dag 131.03.20081
1060 Z51.10Carbo - Paklitaxel Hypersens12.03.20091
0582 Z51.10Carbo 5/ Navelbine 25, dag 124.11.20091
0583 Z51.10Carbo 5/ Navelbine 25, dag 824.11.20091
0581 Z51.10Carbo 5/ Navelbine 25, hele kuren24.11.20098
0778 Z51.10Carbo 6/Navelbine 30 adjuvant dag 116.12.20091
0953 Z51.10Carbo/Eto nevroblastom25.03.20093
0954 Z51.10Carbo/Eto Sasilidar25.03.20093
0198 Z51.10Carboplatin05.03.20091
0805 Z51.10Carboplatin - Caelyx25.02.20101
1143 Z51.10Carboplatin - Etoposid16.05.20113
0451 Z51.10Carboplatin AUC 713.03.20091
0717 Z51.10Carboplatin/Epirubicin05.03.20091
0821 Z51.10Carboplatin/Etoposid-Sarkom12.03.20094
0113 Z51.10CCNU 07.12.20101
0737 Z51.10CDP/ADM-Euroboss1-hørselproblemer12.03.20096
0584 Z51.10CDP1/ADM1 SSG1412.03.20093
0440 Z51.10CDP1/ADM1barn ISG/SSG I12.03.20093
0257 Z51.10CDP1/ADM1voksneISG/SSG I12.03.20093
0677 Z51.10CDP100/ ADM6012.03.20093
0152 Z51.10CEB Dag 1-613.03.20096
0305 Z51.10CEKP23.06.20065
0699 Z51.11Cetuximab - vedlikehold (hver uke)02.09.20111
0862 Z51.11Cetuximab rutine startdose 1.kur25.02.20101
0690 Z51.10CEV12.03.20091
0598 Z51.10CHOEP-1413.12.20055
0697 Z51.10CHOEP-14 + Rituximab24.11.20085
0799 Z51.12CHOEP-14 + Rituximab dag 125.02.20101
0800 Z51.10CHOEP-14 + Rituximab dag 2-528.03.20064
0668 Z51.10CHOEP-2105.12.20055
0725 Z51.10CHOEP21 Rituximab 29.11.20053
0615 Z51.10CHOP-1402.12.20051
0730 Z51.12CHOP-14 + Rituximab14.07.20095
0062 Z51.10CHOP-2103.11.20081
0632 Z51.12CHOP-21 + Rituximab24.03.20101
0603 Z51.10CiFu - øsofagus 16.08.20105
0720 Z51.10CiFu Ani/ Spiserør16.08.20104
1139 Z51.10CiFu NeoRes16.08.20105
0719 Z51.10CiFu Stråle11.10.20054
0175 Z51.10CiFu ØNH16.08.20105
0766 Z51.10Cis 75 - Docetaxel 7525.02.20101
1056 Z51.10Cis/Paclitaxel 3 timer11.03.20091
0669 Z51.10Cis/Paclitaxel/Gemcitabine14.02.20081
0164 Z51.10CisMtxLv22.09.20085
0770 Z51.10Cisplatin 120/Doxorubicin7512.03.20093
0542 Z51.10Cisplatin 2 dager11.03.20092
0715 Z51.10Cisplatin 4 dager11.03.20094
1160 Z51.10Cisplatin 50 Hypersens16.05.20111
1161 Z51.10Cisplatin 50 mg16.05.20111
0802 Z51.10Cisplatin 50 mg / Topotekan 0,75 mg11.03.20093
0817 Z51.10Cisplatin 50/Caelyx 3025.02.20101
0194 Z51.10Cisplatin 75 mg05.03.20091
0806 Z51.10Cisplatin 75 mg 2 dager11.03.20092
0716 Z51.10Cisplatin 75/Gemcitabine 1000mg11.03.20092
0722 Z51.10Cisplatin 75/Gemcitabine 800mg11.03.20092
0494 Z51.10Cisplatin ukentlig11.03.20091
1041 Z51.10Cisplatin ukentlig - DAHANCA 1901.09.20081
1164 Z51.10Cisplatin ukentlig GAND Emesis12.08.20111
1067 Z51.10Cisplatin ukentlig, hode/hals17.11.20082
0193 Z51.10Cisplatin/5FU11.03.20092
0767 Z51.10Cisplatin/5-FU penis14.07.20066
0809 Z51.10Cisplatin/docetaxel25.02.20101
0181 Z51.10Cisplatin/Doksorubicin11.03.20091
0543 Z51.10Cisplatin/doxorubicin11.03.20091
1037 Z51.10Cisplatin/Paclitaxel 24 timer11.03.20092
0786 Z51.10Cisplatin40 Combretastatin ukedos11.03.20091
0776 Z51.10Cisplatin-Navelbine dag 129.10.20101
0064 Z51.10CIVP (peroral CHOP) 06.12.20053
1024 Z51.10Cladribin-kur (LCH-S-98, terapiresistent LCH)05.03.20095
0097 Z51.10CMF22.09.20081
0065 Z51.10CNOP25.09.20091
0955 Z51.10CNS-PNET >4 år ETO/CARBO25.03.20091
0956 Z51.10CNS-PNET >4 år VCR/CCNU25.03.20091
0957 Z51.10CNS-PNET >4 år VCR/Cisplatin19.08.20091
0958 Z51.10CNS-PNET >4 år VCR/Cyklofosfamid25.03.20091
0959 Z51.10COJEC-A (vcr/carbo/eto)25.03.20092
0960 Z51.10COJEC-B (vcr/cisplatin)25.03.20093
0961 Z51.10COJEC-C (vcr/cyk/eto)25.03.20093
0066 Z51.10COP-2131.08.20091
0810 Z51.12COP-21 + Rituximab25.02.20101
1043 Z51.10COPDAC-dag 1-3 EURONET-PHL-C101.09.20083
1044 Z51.10COPDAC-dag 8 EURONET-PHL-C102.09.20081
1061 Z51.10COPP dag 1 Barn25.03.20091
1062 Z51.10COPP dag 8 Barn25.03.20091
1045 Z51.10COPP-dag 1 EURONET-PHL-C102.09.20081
0307 Z51.10COPP-dag 1 og dag 816.08.20061
1046 Z51.10COPP-dag 8 EURONET-PHL-C102.09.20081
0739 Z51.10Cyklo/fludarabin for mini-allo07.09.20095
0723 Z51.10Cyklo/Topo26.06.20085
0754 Z51.12Cytarabin liposomal i.t.25.02.20101
0487 Z51.10Cytosar it 19.12.20081
0183 Z51.10Dactinomycin02.10.20084
0693 Z51.10DHAP14.10.20082
0888 Z51.12DHAP-rituximab25.02.20102
0785 Z51.10Docetax75 Epirubi 60 Carbo5 TEC25.02.20101
1038 Z51.10Docetaxel 7525.02.20101
0718 Z51.10Docetaxel 75/ Carbo 520.05.20111
0626 Z51.10Docetaxel 75/ prednison 1025.02.20101
0712 Z51.10Docetaxel ukedose, 30mg/m2 Gyn03.03.20101
0965 Z51.10Docetaxel/doksorubicin09.03.20101
0860 Z51.10Dokso 50/Ifo5-SSG XX, inne >=70 år12.03.20093
0858 Z51.10Dokso 50/Ifo5-SSG XX, poli >=70 år12.03.20093
0859 Z51.10Dokso 60/Ifo6_SSG XX, poli <70 år12.03.20091
0861 Z51.10Dokso 60/Ifo6-SSG XX, inne <70 år26.06.20093
0780 Z51.10Dokso/ Ifosfamid - Euramos 112.03.20093
0724 Z51.10Dokso50/Ifo5 - sarkom, 2dager12.03.20092
0184 Z51.10Doksorubicin05.03.20091
0774 Z51.10Doksorubicin - Euramos 112.03.20092
0696 Z51.10Doksorubicin 75/4 timer12.03.20091
0695 Z51.10Doksorubicin 90/24 timer12.03.20091
1163 Doksorubicin Ixabepilone studien02.09.20111
1070 Z51.10Doxo Cyklo EPSSG 200525.03.20093
0098 Z51.10Doxorubicin ukedose04.11.20081
0114 Z51.10DTIC07.12.20101
0034 Z51.10ECO26.01.20101
0837 Z51.10ECX epirubicin/cisplatin/xeloda31.03.200821
0838 Z51.10ECX Epirubicin/Cisplatin/Xeloda dag131.03.20081
0740 Z51.10EDP11.03.20094
0026 Z51.10ELF10.01.20063
0729 Z51.10EMA-CNS dag 1+203.10.20082
0156 Z51.10EMA-CO13.03.20098
0657 Z51.10EMA-CO dag 1+203.10.20082
0886 Z51.10EMA-CO dag 8 ca. testis13.03.20091
0655 Z51.10EMA-CO dag 8 trofoblast21.08.20081
0538 Z51.10EMA-EP dag 1+202.10.20082
0539 Z51.10EMA-EP dag 802.10.20081
0068 Z51.10ENAP18.12.20085
1068 Z51.12ENAP+rituximab, dag 125.02.20101
0890 Z51.10ENAP+rituximab, dag 2-301.12.20083
0850 Z51.10EOX Epirubicin/Oxaliplatin/Xeloda20.05.201121
0847 Z51.10EOX Epirubicin/Oxaliplatin/Xeloda_d120.05.20111
0159 Z51.10EP 5 dager11.03.20095
0706 Z51.10EP-GI05.04.20113
0484 Z51.10Epirubicin09.05.20051
0726 Z51.10Epirubicin ukedose22.01.20031
0704 Z51.10EPOCH-F02.10.20095
0743 Z51.10EPOCH-F/R12.08.20115
1170 Z51.10EPOCH-R17.02.20125
0828 Z51.10Eto 100 Ifo 1800, 3 dager28.11.20063
0569 Z51.10Eto1Ifo26.06.20084
0566 Z51.10Eto2Ifo226.06.20086
0694 Z51.10Eto400/Dox7512.03.20093
0827 Z51.10Etoposid + Caelyx25.02.20101
0781 Z51.10Etoposid 500/ Ifosfamid 1400012.03.20095
0467 Z51.10Etoposid kapsler09.03.200621
1065 Z51.10Etoposid-langerhanscellehistiocytose05.03.20093
0836 Z51.10Euro-LB 02 Induk 1A (Kreftklinikken)16.09.200826
0842 Z51.10Euro-LB 02 Induk 1B (Kreftklinikken)16.09.200826
0856 Z51.10Euro-LB 02 Reind 2A (Kreftklinikken)29.04.200822
0855 Z51.10Euro-LB 02 Reind 2B (Kreftklinikken)14.10.200813
0099 Z51.10FAC 26.07.20051
0930 Z51.10Farmorubic/Omnipaque/Lipiodol-TACE11.03.20091
0801 Z51.10FCM28.03.20063
0702 Z51.10FEC 10031.10.20051
0100 Z51.10FEC 6031.10.20051
0934 Z51.10FLAG (AML residiv barn)25.03.20096
0940 Z51.10FLAG + DaunoXome, AML residiv barn25.03.20096
0966 Z51.10FLAG-Ida Kur 122.07.20085
0967 Z51.10FLAG-Ida Kur 222.07.20085
0604 Z51.10FLIRI29.04.20082
0909 Z51.11Fliri - Avastin25.02.20102
0503 Z51.10FLOX20.05.20112
0910 Z51.11Flox - Avastin20.05.20112
0803 Z51.10FLOX adjuvant20.05.20112
0551 Z51.10Fludarabin01.12.20055
0707 Z51.10FLUDARABIN/CYKLOFOSFAMID25.10.20063
0874 Z51.10Fluorouracil/streptozocin induksjon08.01.20101
0013 Z51.10FLv27.02.20092
0607 Z51.10Flv - de Gramont 29.07.20052
0590 Z51.10FLv - STRÅLE15.08.20052
0907 Z51.11Folfiri - Avastin25.02.20101
0107 Z51.10FuMi02.05.20082
0020 Z51.10FuMi-GI02.09.20054
0313 Z51.10GBOH-95; OPPA13.12.200515
0891 Z51.10GemCap01.04.20083
0783 Z51.10GemCarbo dag 103.12.20091
0784 Z51.10GemCarbo dag 803.12.20091
0709 Z51.10GemCarbo GYN dag 105.03.20091
1092 Z51.10Gem-Cis-Tax13.03.20098
0642 Z51.10GEMCIT/CISPL- DAG 8 og DAG 1504.08.20051
0641 Z51.10GEMCIT/CISPL, DAG 1-204.08.20053
0749 Z51.10GEMCIT/CISPL, DAG 1-3 nyresparende04.08.20053
0399 Z51.10Gemcitabin 09.05.20061
0762 Z51.10Gemcitabin 1000, mamma01.07.200915
0670 Z51.10Gemcitabin 800 mg Dag 1 og 812.03.20098
0685 Z51.10Gemcitabin Hodgkin25.11.200515
0792 Z51.10Gemcitabin/ Docetaxl Sarkom, dag 126.06.20091
0793 Z51.10Gemcitabin/Docetaxel Sarkom, dag 825.02.20101
0835 Z51.10Gemcitabin/Vinorelbin, Hodgkin14.02.20088
0306 Z51.10GPOH-95; COPP20.03.200615
0309 Z51.10GPOH-95; IEP 08.05.20067
0310 Z51.10GPOH-95; OEPA02.12.200515
0686 Z51.10HAMMERSMITH -82 - MTX (dag 64-67 og 78-81)14.10.20084
0211 Z51.10HAMMERSMITH -82 RAT (43-48)12.02.20086
0209 Z51.10HAMMERSMITH -82 (1-29)08.02.201029
0591 Z51.10HD - BuEC > 3 år (BFM 95)01.12.20059
0758 Z51.10HD MTX 1,5g > 60 år14.10.20053
0757 Z51.10HD MTX, 3 g14.10.20055
0579 Z51.10HD-BuM28.09.20057
0906 Z51.10HD-BuM - iv17.04.20087
0614 Z51.10HD-CYTARABIN (CNS-lymfom)07.03.20083
0756 Z51.10HD-CYTARABIN 4000, > 60 år14.10.20082
0682 Z51.10HD-CYTARABIN 6000 < 60 år02.02.20102
1089 Z51.12HD-CYTARABIN -RITUXIMAB MANTEL25.02.20102
1090 Z51.12HD-CYTARABIN-RITUXIMAB MANTEL 60-65 år14.03.20112
0514 Z51.10HDEC >16 år12.03.20096
0962 Z51.10Hemangioendotheliom 4 uk. vinkr uknt28.07.200822
0630 Z51.11Herceptin hver 3 uke, 2. kur og senere13.04.20101
0658 Z51.12Herceptin hver 3. uke 1. kur25.02.20101
0744 Z51.12Herceptin Taxotere 3.uke, oppstart14.03.20112
0745 Z51.12Herceptin Taxotere 3.uke, vedlike13.04.20101
0746 Z51.11Herceptin Taxotere ukedose oppstart25.02.20101
0747 Z51.10Herceptin Taxotere ukedose vedlike14.03.20111
0595 Z51.10Herceptin ukent/Navelbine 2.kur+sen19.08.20111
0505 Z51.11Herceptin ukentlig 1. kur25.02.20101
0506 Z51.10Herceptin ukentlig 2. kur og senere10.05.20051
0594 Z51.11Herceptin ukentlig/Navelbine 1. kur25.02.20102
0796 Z51.12Herceptin/Navelbine 1.kur (Hernata)25.02.20101
0592 Z51.11Herceptin/Taxol (ukedose) 1. kur25.02.20102
0593 Z51.10Herceptin/Taxol 2. kur og senere03.03.20101
0197 Z51.10Hexametyl08.05.200614
0972 Z51.10HIT 2000 CARBO/ETO (stPNET)19.08.20093
0973 Z51.10HIT 2000 CARBO/ETO + MTX it25.03.20094
0974 Z51.10HIT 2000 VCR/ MTX 5 gram (stPNET)25.03.20094
0975 Z51.10HIT 2000 VCR/ MTX 5 gram + MTX it25.03.20094
0976 Z51.10HIT 2000 VCR/CYK (stPNET)25.03.20094
0977 Z51.10HIT 2000 VCR/CYK + MTX it25.03.20094
0978 Z51.10HLH Eto24.07.20081
0768 Z51.10Hyper CVAD-Mtx/araC < 60år14.10.20087
0738 Z51.10Hyper-CVAD Cyclo14.10.200811
0979 Z51.10Høydose Ara-C NOPHO-ALL25.03.20094
0980 Z51.10Høydose BUMEL27.03.20098
0981 Z51.10Høydose BUMEL vekt <12 kg27.03.20098
0982 Z51.10Høydose CEM MAT gfr<10027.03.20098
0983 Z51.10Høydose CEM MAT gfr<100 vekt<12 kg27.03.20098
0984 Z51.10Høydose CEM MAT gfr>10027.03.20098
0985 Z51.10Høydose CEM MAT gfr>100 vekt<12 kg27.03.20098
0002 Z51.10HØYDOSE CYKLOFOSFAMID (v/TBI)01.12.20052
0512 Z51.10Høydose Ifosfamid 15g/m211.03.20096
0510 Z51.10Høydose Ifosfamid-10g/m211.03.20096
0619 Z51.10Høydose Ifosfamid-12g/m211.03.20096
0688 Z51.10Høydose Melphalan02.12.20051
0069 Z51.10Høydose mtx 2g/kvm25.07.20081
0986 Z51.10Høydose MTX 5 gram NOPHO-ALL27.03.20094
0987 Z51.10Høydose MTX 8 gram NOPHO-ALL27.03.20094
0988 Z51.10Høydose MTX ekstraark NOPHO-ALL27.03.20092
0509 Z51.10HØYDOSE VIP13.03.20095
0989 Z51.10Idarubicin 5 mg/m2 enkeltdose27.03.20091
1128 Z51.10IEP EuroNet-PHL-C104.06.20105
0678 Z51.10Ifo/Adm 12.03.20093
0680 Z51.10Ifo/CDP12.03.20094
0775 Z51.10Ifo/CDP-Euroboss 1 V/ hørselsproblemer12.03.20095
1069 Z51.10IfoDoxo EPSSG NRSTS 200527.03.20093
0787 Z51.10Ifosfamid 4500 Paclitaxel 17511.03.20093
0804 Z51.10Ifosfamid single03.10.20083
0846 Z51.10IGEV Hodgkin07.09.20094
0586 Z51.10IKE01.09.20093
0917 Z51.10IKE+rituximab01.12.20083
1058 Z51.11IKE+rituximab, dag 125.02.20101
1059 Z51.10IKE+rituximab, dag 2-309.03.20103
1124 Z51.10IME16.04.20105
1127 Z51.10IME dag 2-512.02.20105
1126 Z51.12IME-rituximab dag 125.02.20101
1123 Z51.10IME-rituximab, hele kuren12.02.20105
0990 Z51.10Ind 1 dag 01 NOPHO-ALL27.03.20091
0991 Z51.10Ind 1 dag 08, 15 og 29 NOPHO-ALL27.03.20091
0992 Z51.10Ind 1 dag 22 NOPHO-ALL27.03.20091
0993 Z51.10Ind 1 dag 36 I/VI/EI NOPHO-ALL27.03.20091
1027 Z51.10Ind 1 dag 36 SI / II NOPHO-ALL27.03.20091
0995 Z51.10Ind 1 dag 40, 43 og 47 NOPHO-ALL27.03.20091
0996 Z51.10Ind. 1A dag 08 og 29 EURO-LB 0227.03.20091
0997 Z51.10Ind. 1A dag 15 EURO-LB 0227.03.20091
0998 Z51.10Ind. 1A dag 22 EURO-LB 0227.03.20091
0999 Z51.10Ind. 1A l-asp alene EURO-LB 0227.03.20091
1000 Z51.10Ind. 1B cytarabin 4 d. EURO-LB 0227.03.20094
1001 Z51.10Ind. 1B cytarabin, bare 1 dag27.03.20091
1002 Z51.10Ind. 1B dag 36 Cyk EURO-LB 0227.03.20091
1003 Z51.10Ind. 1B dag 64 Cyk EURO-LB 0227.03.20091
0896 Z51.10Ind. M EURO LB 02_116.09.200811
0916 Z51.10Ind. M EURO LB 02_2 (fra dag 22,36, 50)16.09.20084
1132 Z51.10Ipstyl04.06.20101
0698 Z51.12Irinotecan+Cetuximab < 70 år, 1 kur25.02.20101
0731 Z51.11Irinotecan+Cetuximab <70 årvedlike25.02.20101
0734 Z51.11Irinotecan+Cetuximab >70 år vedlike25.02.20101
0732 Z51.12Irinotecan+Cetuximab >70år, 1.kur18.01.20071
0773 Z51.11Irinotecan+Cetuximab >70år, 3. uke25.02.20101
1145 Z51.12Irinotecan+panitumumab14.03.20111
1165 Z51.10Irinotekan (Campto) 13.05.20111
1166 Z51.10IRIS (Carboplatin+Campto)20.05.20111
1004 Z51.10ISG/SSG III & IV CEto Barn27.03.20094
1005 Z51.10ISG/SSG III & IV VAdmC Barn27.03.20092
1006 Z51.10ISG/SSG III Eto1Ifo Barn27.03.20094
1007 Z51.10ISG/SSG III VIfoAct Barn27.03.20094
1008 Z51.10ISG/SSG IV Eto2Ifo2 Barn27.03.20096
1009 Z51.10ISG/SSG IV VAdmIfo Barn27.03.20093
1071 Z51.10IVA 9 gram MMT 9827.03.20093
1072 Z51.10IVA EPSSG 200527.03.20092
0811 Z51.10IVA - MMT 9512.03.20092
1039 Z51.10IVADo EPSSG 200527.03.20092
1040 Z51.10IVADo EPSSG 2005 >= 15 år27.03.20092
1073 Z51.10IVADo <1 år <=10 kg EPSSG 200527.03.20092
1074 Z51.10IVE MMT 9827.03.20093
1146 Z51.10Ixabepilone studie endometrie16.05.20111
0124 Z51.10Ixotene (Trofosfamid)01.12.20051
1010 Z51.10JEB germinom27.03.20093
1154 Z51.10Karbo - Paklitaxel Hypersens16.05.20111
1156 Z51.10Karbo/Caelyx 30 Hypersens16.05.20111
1155 Z51.10Karbo/Epirubicin Hypersens16.05.20111
1153 Z51.10Karbo/Gemcitabin Hypersens16.05.20111
1142 Z51.10Karbo-Fu Neores16.05.20115
1147 Z51.10Karboplatin - Paklitaxel OCTAVIA16.05.20111
1149 Z51.10Karboplatin - Paklitaxel OVAR 1216.05.20111
1011 Z51.10Konsolidering Ara-C (SI/II) NOPHO-ALL27.03.20094
0945 Z51.10Konsolidering høy intens AML residiv27.03.20095
0926 Z51.10Konsolidering lav intensitet AMLresidiv27.03.20094
1033 Z51.10Lapatinib - Capecitabine07.11.20085
1012 Z51.10LCH-III Vinblastin05.03.20091
1013 Z51.10LCH-III Vinblastin/MTX 0,5 gram05.03.20093
0599 Z51.10Leukeran, syklisk 02.12.20055
0071 Z51.10Leukeran/Prednison 06.12.20051
0790 Z51.10Leustatin14.03.20065
0922 Z51.10Lille BuCy allogen stamcelletx barn27.03.20092
0433 Z51.10LOPP 02.12.200514
1014 Z51.10LSA2L2 kur 1 (I/VI/EI) Bare dag 5!27.03.20091
1015 Z51.10LSA2L2 kur 1 (I/VI/EI) NOPHO-ALL27.03.20095
1016 Z51.10LSA2L2 kur2 (I/VI/EI) Bare dag 5!27.03.20091
1017 Z51.10LSA2L2 kur2 (I/VI/EI) NOPHO-ALL27.03.20095
1018 Z51.10LSA2L2 kur3 (I/VI/EI) Bare dag 5!27.03.20091
1019 Z51.10LSA2L2 kur3 (I/VI/EI) NOPHO-ALL27.03.20095
1020 Z51.10LSA2L2 kur4 (I/VI/EI) NOPHO-ALL27.03.20095
0054 Z51.10LVPP / hele kuren 25.11.200514
0869 Z51.10LVPP dag 1, barn06.05.20101
1021 Z51.10LVPP dag 8, barn27.03.20091
0056 Z51.10LVPP-mini / hele kuren 04.06.201015
0549 Z51.10MAXI-CHOP03.10.20071
0889 Z51.12MAXI-CHOP-rituximab Nordisk MCL III25.02.20101
0256 Z51.10Melfalan-Prednisolon13.12.20054
0436 Z51.10Methotreksat intrathekalt 12mg22.09.20081
0186 Z51.10Methotreksat lavdose02.10.20084
0405 Z51.10Metotrexat intrathekalt 10mg25.08.20051
0489 Z51.10Metotrexat intrathekalt 15mg02.12.20051
0634 Z51.10Mitoksantron / Prednison06.12.20051
0625 Z51.10Mitoksantron og Prednisolon27.02.20071
0200 Z51.10Mitoxantron-Intraperitonealt05.03.20091
0201 Z51.10Mitoxantron-Intrapleuralt05.03.20091
0943 Z51.10ML DS 2007 kur haM < 1 år / 12 kg27.03.20094
0119 Z51.10MTX - Euramos 124.06.20093
0679 Z51.10MTX - Euroboss 124.06.20094
0713 Z51.10MTX intrathecal Gyn02.10.20081
0176 Z51.10MTX ukedose27.05.20051
0616 Z51.10MTX-CNS-lymfom20.11.20064
1171 Z51.10MTX-R-CHOD-CHIC > 60 1. kur03.02.20124
1172 Z51.10MTX-R-CHOP-CHIC 1. KUR03.02.20124
0171 Z51.10M-VAC (dag 1-2)24.10.20053
0172 Z51.10M-VAC (dag 15+22)04.08.20058
0170 Z51.10M-VAC (hele)24.10.200522
0617 Z51.10Navelbine 25 mg/m210.04.20081
0779 Z51.10Navelbine adjuvant dag 829.10.20101
0849 Z51.10Naxogin 1 dag24.08.20071
0652 Z51.10NOPHO - HD Mtx 8g16.11.20024
0919 Z51.10NOPHO-AML kur AIET >1år >10 kg27.03.20096
0923 Z51.10NOPHO-AML kur AIET infant / <10 kg27.03.20096
0935 Z51.10NOPHO-AML kur AM >1år >10 kg27.03.20096
0946 Z51.10NOPHO-AML kur AM infant / <10 kg27.03.20096
0918 Z51.10NOPHO-AML kur HA1M >1år >10 kg27.03.20095
0921 Z51.10NOPHO-AML kur HA1M infant /<10kg27.03.20095
0925 Z51.10NOPHO-AML kur HA2E >1år >10 kg27.03.20095
0944 Z51.10NOPHO-AML kur HA2E infant / <10 kg27.03.20095
0920 Z51.10NOPHO-AML kur HA3 infant / <10kg27.03.20094
0851 Z51.10NOPHO-AML kur HA3 >1 år >10 kg27.03.20094
0651 Z51.10NOPHO-HD-Cytarabin14.10.20085
0863 Z51.10Nordisk PCNSL blokk A1 66 år og over16.09.20085
0899 Z51.10Nordisk PCNSL blokk A1 under 6618.09.20085
0868 Z51.10Nordisk PCNSL blokk A2 under 6618.09.20085
0902 Z51.10Nordisk PCNSL blokk B1-A2-B2 _66 år og over18.09.20086
0854 Z51.10Nordisk PCNSL blokk B1-B2 under 6616.09.20085
0903 Z51.10Nordisk PCNSL blokk C1-C2 over 6524.04.20083
0915 Z51.10Nordisk PCNSL blokk C1-C2 under 6624.04.20083
0312 Z51.10OEPA (DAG 15)20.03.20061
0311 Z51.10OEPA (DAG 1-8)31.08.20098
1022 Z51.10OEPA dag 1 Barn27.03.20091
1023 Z51.10OEPA dag 1 EuroNet-PHL-C1 Barn27.03.20091
1025 Z51.10OEPA dag 15 Barn27.03.20091
1026 Z51.10OEPA dag 2-5 EuroNet-PHL-C1 Barn27.03.20094
1028 Z51.10OEPA dag 3-6 Barn27.03.20094
1029 Z51.10OEPA dag 8 Barn27.03.20091
0897 Z51.10OEPA EURONET-PHL-C1 (DAG 15)09.03.20101
0898 Z51.10OEPA EURONET-PHL-C1 (DAG 1-8)19.12.20088
0818 Z51.10OI-testis13.03.200915
0820 Z51.10OI-testis dag 813.03.20091
0420 Z51.10OPAL (residiv/eldre) 18.01.20066
0314 Z51.10OPPA (DAG 15)04.05.20061
0315 Z51.10OPPA (DAG 8)04.05.20061
1030 Z51.10OPPA dag 1 Barn27.03.20091
1031 Z51.10OPPA dag 15 Barn27.03.20091
1032 Z51.10OPPA dag 8 Barn27.03.20091
1141 Z51.10Oxali-Fu NeoRes03.09.20105
0819 Z51.10Oxaliplatin - Irinotekan dag 1 og 1513.03.20091
0826 Z51.10Oxaliplatin 13005.03.20091
0735 Z51.10Oxaliplatin-stråle31.03.20081
0807 Z51.10Paclical05.03.20091
0203 Z51.10Paclitaxel05.03.20091
0531 Z51.10Paclitaxel - Carboplatin07.12.20101
0485 Z51.10Paclitaxel - Carboplatin (vesica)20.05.20081
0654 Z51.10Paclitaxel 24 t + Carboplatin05.03.20092
1148 Z51.10Paclitaxel dag 8 og 15 OCTAVIA16.05.20111
1162 Z51.10Paclitaxel Ixabepilone studien02.09.20111
0588 Z51.10Paclitaxel/Gemcitabine Gyn12.03.20091
0618 Z51.10Paclitaxel-Gemcitabin13.03.20091
0126 Z51.10PAI12.03.20095
1144 Z51.10Paklitaxel/etopsoid/carboplatin16.05.20114
1159 Z51.11Paklitaxel/Topotecan cervix14.03.20113
1121 Z51.12Panitumumab11.06.20101
0710 Z51.10PC/PE Dag 1 Gyn03.03.20061
0711 Z51.10PC/PE Dag 15 Gyn02.10.20081
0011 Z51.10PCV03.12.20091
0161 Z51.10PEI 13.03.20095
0496 Z51.10PIFL03.03.20102
0550 Z51.10PRECORTALON 02.12.20051
1169 Z51.10Prefase_CHIC03.02.20125
0970 Z51.10Promyelocyttleukemi, Induksjon24.07.20087
0968 Z51.10Promyelocyttleukemi, Konsolidering 124.07.20087
0969 Z51.10Promyelocyttleukemi, Konsolidering 224.07.20084
1034 Z51.10Protocol M: MTX 5 gram EURO-LB 0227.03.20094
0782 Z51.10PV - 3 dager iv03.12.20093
0035 Z51.10PV - standard03.12.20094
1035 Z51.13RALLE A1 NOPHO-ALL residiv14.03.20111
1036 Z51.11RALLE A2 NOPHO-ALL residiv25.02.20101
1081 Z51.10RALLE res u4 NOPHO-ALL residiv27.03.20091
1082 Z51.10RALLE res u5 NOPHO-ALL residiv27.03.20091
1077 Z51.10RALLE resp C2 araC NOPHO-ALL res27.03.20094
1079 Z51.13RALLE resp u2 (A3) NOPHO-ALL res14.03.20111
1080 Z51.13RALLE resp u3 (A4) NOPHO-ALL res14.03.20111
1093 Z51.10RALLE sen intens u3 NOPHO-ALL res09.03.20101
1083 Z51.13RALLE senintens u0 NOPHO-ALL res14.03.20111
1103 Z51.10Re-ind II/b AraC d 38, 45 EURO LB 0209.03.20101
1096 Z51.10Re-ind. II/a dag 8 og 15 EURO-LB 0209.03.20101
0464 Z51.11Rituximab10.11.20111
0621 Z51.10RITUXIMAB-FCM18.12.20084
1125 Z51.10Rituximab-Fludara-Cyklof. dag 2-312.02.20103
1091 Z51.10Rituximab-Fludara-Cyklofosfamid09.02.20103
1122 Z51.12Rituximab-Fludara-Cyklofosfamid d.125.02.20101
0839 Z51.13Rituximab-Zevalin standard25.02.20108
0791 Z51.13Rituximab-Zevalin studie25.02.20101
1134 Z51.10Sandostatin LAR14.03.20111
1112 Z51.10Sen int. interm. Ara-C NOPHO-ALL14.07.20094
1113 Z51.10Sen int. interm. cyklofos NOPHO-ALL14.07.20091
1115 Z51.10Sen int. interm. d04/11 NOPHO-ALL09.03.20101
1109 Z51.10Sen intensiv. (I/VI) d08 NOPHO-ALL09.03.20101
1111 Z51.10Sen intensiv. (I/VI) d22 NOPHO-ALL09.03.20101
1114 Z51.10Sen intensiv. interm. d01 NOPHO-ALL09.03.20101
1047 Z51.10SIOP PNET4 Dag 102.09.20081
0870 Z51.10Streptozocin/ mitotane vedlikehold10.03.20081
0872 Z51.10Streptozocin/mitotane induksjon29.01.20103
0824 Z51.10SUTENT, 1 dag02.01.20071
0823 Z51.10SUTENT, hele kuren02.01.200728
0601 Z51.10Taxol ukentlig - 80 - 90 mg/m202.05.20111
0112 Z51.10Taxotere 100 hver 3. uke (mammae)25.02.20101
0548 Z51.10Taxotere 75 mg/m2-2 linje behandling25.02.20101
0040 Z51.10Taxotere ukedose 20 mg/m224.11.20091
0659 Z51.10Taxotere ukedose, 30 mg/m201.12.20061
0628 Z51.10Taxotere ukedose, 35 mg/m228.09.20051
1063 Z51.10Taxotere-cyklof hver 3.uke -mammae09.03.20101
0808 Z51.10TCG dag 1 Trofoblast06.10.20081
0540 Z51.10TEC05.03.20091
0587 Z51.10Temodal07.12.20105
0822 Z51.10Temodal 75 mg/m203.12.20091
0931 Z51.10Temsirolimus (Torisel)15.09.20081
0495 Z51.10TIP13.03.20095
0466 Z51.10Tomudex 15.08.20051
0534 Z51.10Topotecan05.03.20095
0653 Z51.10Topotecan 5 dager11.08.20055
1057 Z51.10Topotecan ukentlig03.03.20101
0894 Z51.10TPF ØNH29.04.20085
0643 Z51.10Trippel intrathecal13.10.20081
0867 Z51.10TVD nevroblastom27.03.20096
1075 Z51.10VA EPSSG 200527.03.20091
1076 Z51.10VA <1 år <=10 kg EPSSG 200527.03.20091
1130 Z51.10VAC Euro Ewing voksne18.02.20112
0258 Z51.10VAD 13.12.20054
0568 Z51.10VAdm1Ifo126.06.20083
0570 Z51.10VAdm2C226.06.20082
0564 Z51.10VAdmC124.06.20082
0127 Z51.10VAI12.03.20095
0259 Z51.10VBAP 13.12.20051
1095 Z51.10Vcr/ Cisplatin LGG 2004 < 10 kg30.04.20093
1094 Z51.10Vcr/Cyk UKCCSG CNS9204 Baby brain09.03.20102
0447 Z51.10VEC 14.10.20053
0437 Z51.10VeIP13.03.20095
1118 Z51.10Velbe07.12.20101
0470 Z51.10Velbe-prednisolon28.11.20051
0128 Z51.10VI11.03.20093
1120 Z51.10VIDAZA23.02.20107
0565 Z51.10VIfoAct24.06.20084
0129 Z51.10VIG11.03.20093
1138 Z51.13Vinflunine14.03.20111
0404 Z51.10Vinkristin 18.10.20051
0571 Z51.10Vinkristin 1,5 mg/m219.08.20091
1129 Z51.10Vinkristin vorfase FLYER09.12.20111
0163 Z51.10VIP13.03.20095
0521 Z51.10VORPHASE, GMALL -0223.02.20105
0596 Z51.10Xeloda 31.03.200814
0763 Z51.10Xeloda - Taxol ukedose12.02.20091
0769 Z51.11Xeloda - Taxotere hver 3. uke22.02.20061
0666 Z51.10Xelox (oxaliplatin-capecitabine)31.03.200814
0667 Z51.10Xelox (oxaliplatin-capecitabine) dag131.03.20081
0857 Z51.13Yondelis12.03.20091
1051 Z51.10Zalutumomab-Cisplatin - DAHANCA 1912.09.20081
1050 Z51.10Zalutumumab DAHANCA 1912.09.20081
0580 Z51.10AA-24 > 3år (BFM 95)14.10.20085
Antall treff 604 kurer
Det er viktig å huske på at verken registeret eller arbeidsskjemaene vil kunne erstatte kunnskap og erfaring i onkologi og sykepleie. Disse nettsidene er ingen lærebok i hvordan administrere cytostatika. Vær oppmerksom på at en del av arbeidsskjemaene trenger tilleggsskjema for fullstendig observasjon. Klikk på ikonet for å laste ned kurlisten ovenfor som Excel-dokument (.xls). 

 

 

 

 

 
search